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SUMMARY 
 
 
 
Membrane fusion is an essential step in the infection cycle of enveloped viruses, 
occurring either at the host cell surface or – after virus uptake by receptor-
mediated endocytosis – in endosomes. The merger of the viral with a cellular 
membrane leads to the release of the viral genome into the host cell cytoplasm 
and to the initiation of the viral replication cycle. This process is mediated by 
conformational changes of so-called viral fusion proteins.  
Flaviviruses are small, enveloped viruses that comprise important human 
disease agents including yellow fever virus, dengue virus, Japanese encephalitis 
virus, West Nile virus, and tick-borne encephalitis virus. Flavivirus membrane 
fusion occurs in endosomes, where the acidic environment triggers irreversible 
conformational changes in the major envelope glycoprotein E, a class II fusion 
protein, that are essential for driving fusion. The molecular structure of the pH-
sensor in E has not yet been resolved. 
At the surface of infectious virions, E proteins form arrays of metastable 
homodimers. Each monomeric subunit is composed of three distinct domains. 
Upon contact to slightly acidic pH, the dimeric E proteins rearrange into trimeric, 
stable post-fusion structures. The structures of soluble forms of E (sE) have 
been resolved by X-ray crystallography in both their pre- and post-fusion 
conformations for several flaviviruses. The sE structures, however, lack the C-
terminal membrane anchor and the so called stem region that connects the 
ectodomain with its anchor. Both are about 50 amino acids in length, contain two 
alpha helices and their roles in the membrane fusion process has not been 
investigated so far.  
The main focuses of this thesis were to investigate through mutagenesis 
approaches (I) the structural basis of the low pH trigger for flaviviruses cell entry 
and (II) the role of the membrane anchor in the fusion process. As a prerequisite, 
quality controls of the experimental model system had to be established (III). 
In the first part of the thesis, the role of specific conserved histidines as pH 
sensors in flavivirus fusion was elucidated. Five histidines within the E protein 
are absolutely conserved among all flaviviruses and – because of their pKa 
 8
around 6.6 – have been hypothesized to function as molecular sensors for 
initiating fusion. In this work the so-called “histidine switch hypothesis” – 
assuming that the flavivirus fusion protein would be activated by changing the 
protonation state of specific histidines – was experimentally tested for the first 
time in a mutagenesis study using recombinant subviral particles (RSPs) of tick-
borne encephalitis virus (TBEV). The experimental results showed that the 
initiation of fusion requires the protonation of one highly conserved histidine 
located at the interface of two domains of E. Another histidine residue at the 
same interface may have a contributing role. The remaining three conserved 
histidines – located at different sites of E – however, were completely 
dispensable for initiating fusion. 
In the second part, the functional role of one of the transmembrane domains of 
the E protein was investigated. The flavivirus E protein is the only known viral 
fusion protein with a membrane anchor consisting not only of one but of two 
transmembrane helices (TM1 and TM2). The functional role of TM2 in fusion 
was unknown and was investigated by the use of RSPs with C-terminally 
truncated E proteins that lack this domain. The experimental results clearly 
showed, that the initiation of fusion and the low pH-induced transitions of E were 
independent of the presence of TM2. However, in the absence of TM2 fusion 
was blocked at an intermediate stage, possibly related to a significantly reduced 
stability of the truncated E trimers formed.  
The third part of the thesis describes the establishment of a suitable model 
system to investigate flavivirus membrane fusion by mutational analysis as has 
been done in parts one and two. RSPs are excellent tools for this purpose 
because they carry the E protein in a virus-like conformation at their surface and 
display fusion characteristics similar to those of the native flaviviruses. The 
development and use of experimental procedures to investigate specific 
parameters of mutant RSPs is reported. 
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I. GENERAL INTRODUCTION 
 
 
 
1. Viral entry into host cells 
 
 
Viruses have evolved to enter host cells and use the cellular machinery for their 
own replication. Based on the presence or the absence of a host cell-derived 
lipid bilayer membrane, viruses are broadly classified into enveloped and 
nonenveloped viruses. For cell entry, both groups of viruses have to recognize 
receptors and need to overcome a cellular membrane. The mechanisms used 
display similarities as well as striking differences (Harrison, 2007).  
 
 
1.1. Cell entry by enveloped viruses: Membrane fusion 
 
Whereas nonenveloped viruses deliver their genome by pore formation or a 
related membrane permeabilizing event (Zhang et al., 2006, Harrison, 2008a; 
Ivanovic et al., 2008; reviewed in Banerjee and Johnson, 2008), enveloped 
viruses fuse their membrane with a cellular membrane to release the viral 
genome into the host cell cytoplasm. Membrane fusion (the merging of two 
separate lipid bilayers) of enveloped viruses can occur either at the plasma 
membrane or in endosomes after virus uptake by receptor-mediated endocytosis 
(reviewed in Smith and Helenius, 2004). Viral membrane fusion does not occur 
spontaneously, but requires the activation of viral transmembrane glycoproteins, 
so-called viral fusion proteins (reviewed in Harrison, 2008b; White et al., 2008).  
Membrane fusion is also a fundamental process in cell biology, including 
reactions such as intracellular fusion of organelles or cell to cell fusion during 
fertilization. All cellular fusion processes share common principles and are 
mediated by proteins that initiate the recognition of the membranes destined for 
fusion and pull them close together to initiate mixing of the lipids (reviewed in 
Jahn, Lang and Südhof, 2003; Sollner, 2004; Chen and Olson, 2005; Martens 
and McMahon, 2008). 
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2. Viral fusion-proteins and -mechanisms 
 
 
Fusion of most viruses is mediated by a single type of fusion protein. More 
complex viruses use a diverse set of two (Poxviruses) or more (Herpesviruses) 
envelope proteins for cell entry (Spear and Longnecker, 2003; Krummenacher et 
al., 2005; Moss, 2006). Viral fusion proteins can be either monofunctional 
(mediating fusion only) or bifunctional (mediating receptor binding and fusion). 
They are often synthesized as inactive precursor proteins that need a proteolytic 
cleavage event to be primed for subsequent activation. Thus many fusion 
proteins are C-terminal fragments of their precursors. Fusion protein maturation 
cleavage (priming) for most viruses, including alpha-, flavi-, retro-, paramyxo- 
and several influenza viruses, is dependent on intracellular cleavage by furin or 
related proteases (reviewed in Klenk and Garten, 1994). Either the fusion protein 
itself is cleaved (e.g. influenza viruses) or an accompanying protein (alpha- and 
flaviviruses). Maturation cleavage can also occur after virus release by 
extracellular proteases (certain influenza strains) and after virus entry in 
endosomes by cathepsins (SARS virus and other Coronaviruses, Ebola virus) 
(Wengler and Wengler, 1989; Stieneke-Göber et al., 1992; Stadler et al., 1997; 
Elshuber et al., 2003; Chandran et al., 2005; Simmons et al., 2005; Schornberg 
et al., 2006; Qiu et al., 2006; Bosch, Bartelink and Rottier, 2008).  
A proteolytically primed fusion protein is typically metastable in its pre-fusion 
conformation, i.e. has not yet reached its lowest energy conformation. In this 
metastable state, the fusion peptides – conserved hydrophobic sequence 
elements that can insert into the target membranes and thus initiate fusion – are 
hidden within the oligomeric structure of the fusion proteins.  
To reach the energetically lower post-fusion structure a kinetic barrier has to be 
overcome by activation of the proteins. Different triggers for the activation of the 
viral fusion proteins have been described (reviewed in Earp et al., 2005; White et 
al., 2008). In some cases, like human immunodeficiency virus (HIV), the 
triggering event is a specific interaction with cell surface based receptors of the 
target cell at neutral pH. In many other cases, including flaviviruses, the trigger is 
exposure to low pH (binding of protons) within endosomes following virus uptake 
via receptor-mediated endocytosis (Helenius et al., 1980). A third mechanism 
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that is found in alpharetroviruses requires the combination of receptor 
interactions at neutral pH and subsequent further activation at acidic pH (Mothes 
et al., 2000). Upon activation, the fusion proteins undergo large scale 
conformational changes (the pre- to the post-fusion transition) that are the 
driving force for the merger of the two membranes.  
 
 
2.1. Structural classes of viral fusion proteins 
 
Two different classes of viral fusion proteins have been defined on the basis of 
structural criteria. Recently, a third class has been introduced that combines 
structural features of the other two classes. Class I viral fusion proteins are 
found in corona-, filo-, orthomyxo-, paramyxo-, and retroviruses, class II fusion 
proteins in alpha- and flaviviruses. The atomic structures of the Vesicular 
stomatitis virus (VSV) G protein (Roche et al., 2006; Roche et al., 2007), the 
glycoprotein B of Herpes simplex virus 1 (HSV1) (Heldwein et al., 2006) and the 
baculovirus gp64 protein (Kadlec et al., 2008) showed surprising similarities 
between the fusion proteins of these quite unrelated viruses. They currently form 
the group of class III viral fusion proteins. 
 
 
2.2. Characteristics of class I fusion proteins 
 
Class I fusion proteins are synthesized as single chain precursors (Fig. 1), that 
subsequently assemble into homotrimers. Cleavage of the fusion-inactive 
precursor protein by host cell proteases is required to form a fusion competent 
protein. Common characteristics of class I fusion proteins are the refolding into a 
highly stable rod like post-fusion structure and a region dominated by alpha 
helical structures termed six-helix bundle (reviewed in Kielian and Rey, 2006). 
The prototype of a class I viral fusion protein is the influenza virus hemagglutinin 
(HA) that will be used here to describe important common features of the class I 
proteins. 
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Figure 1. Schematic representation of class I viral envelope glycoprotein precursors.    
Class I envelope proteins are synthesized as single chain precursors that assemble into 
trimers. The precursors contain a signal sequence (purple), a proteolytic cleavage site (arrow), 
the fusion peptide (red) and a carboxy-terminal transmembrane anchor (green). Sequences 
with helix forming propensity are indicated in blue and yellow. (A) Influenza, HA. (B) 
Paramyxovirus F, (C) HIV gp160 (Reproduced from Colman and Lawrence, 2003). 
 
 
2.2.1. The Influenza virus hemagglutinin (HA) 
 
So far, the influenza virus HA is the most extensively studied viral fusion protein. 
It was the first to be structurally characterized in pioneering work by Don Wiley 
and John Skehel in both its pre- and post-fusion conformations (Wilson, Skehel 
and Wiley, 1981; Wiley, Wilson and Skehel, 1981; Bullough et al., 1994).  
HA is synthesized as a single-chain precursor (HA0, Fig. 1 A) that is cleaved by 
host cell proteases resulting in HA1 and HA2 subunits that are connected via a 
disulphide bond. Proteolytic priming of HA0 does not change the overall structure 
of the HA1/HA2 complex, but results in the formation of a pocket in which the first 
22 amino acids of HA2 – forming the fusion peptide (FP) – are hidden. HA1 
contains the receptor binding site. The influenza virus receptor is sialic acid 
which is present on many cellular membrane glycoproteins. HA2, which forms 
three alpha helical coiled coils, contains the fusion peptide and is the 
transmembrane subunit anchoring the protein in the viral membrane (reviewed in 
Skehel and Wiley, 2000).  
Figure 2 shows the influenza virus HA in its pre- and post-fusion conformations. 
In the pre-fusion conformation, the sialic acid sensing subunit HA1 covers HA2 
(Fig. 2 A). Exposure to low pH in endosomes following sialic acid-mediated 
(C) 
(B) 
C N 
HA0 
HA1 HA2 
F2 
F0 
F1 
C N 
gp160 
C N 
gp120 gp41 
(A) 
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uptake into the host cell triggers a major rearrangement of the HA1/HA2 complex. 
HA1 dissociates and moves sideward, allowing HA2 to adopt its post-fusion 
conformation that reassembles into a stable rod like structure with the fusion 
peptide and the transmembrane segments at the same end of the molecule (Fig. 
2 B). This structure is also referred to as “trimer of hairpins” (reviewed in Kielian 
and Rey, 2006). 
 
 
 
 
Figure 2.  Structural representations of the pre- and post-fusion conformations of 
influenza HA. Fig. 2 A shows the HA1/HA2 complex in its native conformation as it occurs at 
the surface of infectious influenza virions. The receptor binding subunit HA1 is colored grey 
and HA2 is colored in red and blue. The fusion peptide (aa 1-22) is indicated by an arrow and 
is colored orange. Fig. 2 B shows the crystallized parts of HA2 in its post-fusion conformation. 
The C-terminal part is colored red and the N-terminal part blue. The transmembrane domain 
of one HA subunit is indicated as a red tube (Fig. 2 A, B). One fusion peptide is indicated as 
an orange tube (Fig. 2 B). Drawn with PyMOL (DeLano, 2002). 
 
 
 
 
 
(A) (B)
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2.2.2. Model of membrane fusion mediated by HA 
 
The knowledge of the pre- and the post-fusion structures of HA and several 
other class I fusion proteins – together with results from biochemical studies – 
allowed the development of a general, but hypothetical, model of the membrane 
fusion mechanism mediated by class I fusion proteins. This model is depicted in 
Figure 3 making use of the influenza HA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Hypothetical model of the class I fusion process mediated by influenza HA2. (A) 
The metastable pre-fusion conformation of HA2. For clarity the HA1 trimer is not shown. The 
fusion peptides are buried in a pocket provided by the adjacent monomeric subunits. (B and C) 
After exposure to low-pH, HA1 dissociates (not shown) and HA2 adopts an extended intermediate 
conformation. The fusion peptides insert into the target bilayer. (D) The parts of HA2 close to the 
C-terminus fold back along the outside of the trimeric coiled coil, thereby distorting the 
membranes and bringing them in close vicinity. (E) A hemifusion stalk is formed in which the 
outer leaflets of the lipid membranes mix. (F) HA2 in the stable post-fusion conformation. The 
fusion peptides and TM domains are close to each other at the same end of the molecule and a 
fusion pore has formed that allows the release of the viral nucleocapsid (adapted from 
Mukhopadhyay et al., 2005).  
 
 
Two key features are typical for the refolding of class I fusion proteins mediating 
membrane fusion: (I) The formation of an extended intermediate coiled-coil 
structure. In the case of influenza HA this intermediate structure is formed by a 
a b c
d e f
(A) (B) (C)
(D) (E) (F)
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loop-to-helix transition of a polypeptide segment of HA2 that was previously 
buried underneath HA1, leading to the exposure of the fusion peptides (Fig. 3 B, 
C). (II) The collapse of this intermediate to generate the post-fusion structure. In 
HA2 the C-terminal end of the long helix “jackknifes” back and zips up alongside 
the extended core structure. This change in the HA2 structure distorts the viral 
and the host cell membrane and brings them in close proximity. It also brings 
together the fusion peptides and the transmembrane (TM) anchors (Fig. 3 D) 
(Harrison, 2008b).  
The proximal membrane leaflets mix first. This intermediate situation – when the 
inner leaflets have not mixed yet – is described as a hemifusion state (Fig. 3 E) 
(Chernomordik and Kozlov, 2005, 2008). When the C-terminal part of HA2 
relocates, the trimer presumably bends away from the hemifusion stalk to 
facilitate the mixing of the membranes (Fig. 3 E). 
In the post-fusion conformation the fusion peptides and the TM domains are 
juxtaposed at the same end of the trimer and interactions between residues of 
the fusion peptides with both, residues of the coiled coil and of the N-terminal 
end of the TM anchors, were discussed (Harrison, 2008b). Specifically, these 
interactions are thought to contribute to the formation of a cap-like structure – at 
the N-termini of the coiled coil – that may be important for the transition from 
hemifusion to the opening of the fusion pore (Chen, Skehel and Wiley, 1999; 
Park, Gruenke and White, 2003). 
 
 
2.3. Characteristics of class II fusion proteins 
 
The three-dimensional structures of class II fusion proteins are radically different 
from class I proteins which are trimeric in both their pre- and post-fusion 
conformations. Class II fusion proteins – that are predominantly composed of 
beta-sheets – mediate fusion by their conversion from a metastable homo- or 
heterodimeric conformation to a considerably more stable post-fusion 
homotrimer. In addition to molecular architecture and oligomeric structure, class 
II differ from class I proteins in terms of maturation cleavage. In contrast to class 
I fusion proteins, they are not cleaved themselves during particle maturation but 
an associated protein with chaperone function is processed.  
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So far, class II fusion proteins have been found in alpha- and flaviviruses. Here 
flaviviruses will be used as a model to describe the properties of a representative 
class II viral fusion protein.  
 
 
2.3.1. Flaviviruses: Assembly, maturation and structures 
 
Flaviviruses are small, enveloped, positive-strand RNA viruses with a diameter 
of approximately 500 Å. They form a genus within the family Flaviviridae that 
consists of about 70 members including several important human pathogens like 
yellow fever (YF), dengue (Den), West Nile (WN), Japanese encephalitis (JE) 
and tick-borne encephalitis (TBE) viruses. Most of them are transmitted to their 
vertebrate hosts by arthropods (mosquitoes or ticks) and can cause fevers, 
hemorraghic fevers and encephalitis in humans. 
The structural organization of flaviviral particles as well as the viral genome and 
the life cycle are shown in Figure 5. Flaviviruses consist of an isometric 
nucleocapsid, composed of a single protein termed C (capsid), surrounded by a 
lipid bilayer containing two membrane-associated proteins designated E 
(envelope) and M (membrane, synthesized as its precursor prM) (Fig. 5 A). The 
genome is about 11,000 nt in length and contains a single open reading frame 
(ORF) with non coding regions at its 5’ and 3’ ends (Fig. 5 B). The structural 
proteins (C, prM/M, E) are encoded in the 5’ terminal third of the ORF. The rest 
of the ORF codes for non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, 
NS4B, NS5) (reviewed in Mukhopadhyay, Kuhn and Rossmann, 2005; Stiasny 
and Heinz, 2006; Lindenbach, Thiel and Rice, 2007). 
Virus assembly occurs in the endoplasmatic reticulum (ER) (Mackenzie and 
Westaway, 2001; Lorenz et al., 2002) (Fig. 5 C) and results in the formation of 
immature virus particles containing heterodimeric complexes of prM and E 
proteins. These prM/E complexes give the immature particles a spiky surface 
(Zhang et al., 2007) (Fig. 6 A). Immature flavivirus particles are transported 
through the Golgi complex into the acidic environment of the trans-Golgi network 
(TGN) where low pH triggers a conformational change in the protein complex 
that allows cleavage of prM into pr and M by furin or a related protease (Stadler 
et al., 1997; Elshuber et al., 2003, reviewed in Klenk and Garten, 1994). 
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Figure 5. Schematics of flavivirus particles (A),  genome organization (B), and the viral 
life cycle (C). (A): Flavivirus particle in its immature (left) and mature (right) form. Immature 
particles contain heterodimeric complexes of prM and E proteins. prM is cleaved during 
particle maturation, resulting in the reorganization of E into homodimers on the surface of 
mature virions. (B): The positive-stranded flavivirus RNA genome with the long ORF 
encoding structural proteins C, prM, E and seven non-structural proteins. (C): The Flavivirus 
life cycle. Infectious viruses are internalized by receptor mediated endocytosis. The acidic pH 
in the endosomes triggers conformational changes in E resulting in membrane fusion and the 
release of the nucleocapsid into the cytoplasm. After uncoating, the RNA genome is 
translated and viral replication begins. Assembly takes place in the ER and results in the 
formation of immature particles. Particles are transported through the exocytic pathway 
where maturation cleavage occurs. Mature virus particles are released via exocytosis (from 
Stiasny and Heinz, 2006). 
 
 
(B)(A) 
(C) 
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After maturation cleavage, E is rearranged at the particle’s surface and primed 
for subsequent activation to mediate membrane fusion. Immature (prM 
containing) flavivirus particles do not fuse because the prM protein has the 
function of a chaperone and prevents the conformational changes in E that 
would result in premature membrane fusion upon exposure to low pH in the TGN 
(Heinz et al., 1994). The cleaved pr peptide stays associated with the complex – 
after the maturation cleavage has occurred – until the virion is released into the 
extracellular space where neutral pH conditions induce the dissociation of pr (Li 
et al., 2008; Yu et al., 2008).  
The structures of whole flavivirus particles have been determined by cryo 
electron microscopy (cryo-EM) using Dengue 2 and West Nile virus and fitting 
the already known structure of the envelope protein E in the EM density map 
(Rey et al., 1995; Kuhn et al., 2002; Mukhopadhyay et al., 2003; Kaufmann et 
al., 2006). These studies revealed the structural organization of flavivirus 
particles, especially of the envelope that contains 90 dimers of E. The native 
viral surface is smooth (Fig. 6 B) and organized in rafts of three E homodimers 
oriented in parallel that form a herringbone-like icosahedral lattice (Fig. 6 C) 
(Kuhn et al., 2002; Mukhopadhyay et al., 2003; Mukhopadhyay et al., 2005).  
 
 
Figure 6. Reconstructions of flavivirus particles. (A): Cryo-EM reconstruction of an immature 
Dengue virus particle with one prM/E “spike” highlighted (green: E, grey: prM). From Zhang et 
al., 2003b. (B): Mature Dengue particle from Kuhn et al., 2002. (C): Organization of E proteins 
across the surface of a mature flavivirus particle. The E dimers are packed in a herringbone-like 
arrangement. Twofold, threefold and fivefold symmetry axes are labelled 2, 3 and 5 respectively. 
(D): Structural organization of a subviral particle of TBE virus. Prepared with PyMol (DeLano, 
2002). 
300Ǻ 
5 
2 3 3 
(A) (B) (C)
(D) 
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In addition to infectious virions also small non-infectious particles are released 
from flavivirus-infected cells, which are natural by-products of infection (Stollar, 
1969; Smith et al., 1970). These have been termed “slowly sedimenting 
hemagglutinin” (SHA) because – like the virions – they are capable of 
agglutinating red blood cells at acidic pH conditions. Such subviral particles can 
be produced in recombinant form by the coexpression of E and prM. They lack 
the nucleocapsid but contain E and M proteins in a lipid membrane, indicating 
that the formation of the particles is not absolutely dependent on the presence of 
the C protein, but is driven by lateral interactions of E and prM (reviewed in 
Heinz and Allison, 2000, 2003; Stiasny and Heinz, 2006). The structure of a 
flavivirus recombinant subviral particle has been resolved by cryo-EM and image 
reconstruction (Ferlenghi et al., 2001). It displays a T=1 icosahedral 
arrangement of 30 E dimers (Fig. 6 D).  
 
 
2.3.2. The flavivirus envelope protein E 
 
E is a prototypic bifunctional class II viral fusion protein. Soluble forms of the pre- 
as well as the post-fusion structures of the flavivirus envelope proteins (lacking 
the transmembrane anchors and a ~ 50 amino acids “stem” region) are known in 
atomic detail. The structure of the TBEV E protein in its pre-fusion form has been 
determined to 2Å resolution by X-ray crystallography of a soluble dimeric 
fragment (Heinz et al., 1991; Rey et al., 1995). Also the structures of the soluble 
E proteins (sE) of pre-fusion dimers of DenV2, DenV3 and monomers of WNV 
are known from truncated recombinant proteins expressed in insect cells (Modis 
et al., 2003; Zhang et al., 2004; Modis et al., 2005; Nybakken et al., 2006). The 
structures of sE post-fusion trimers have been determined for TBEV (Bressanelli 
et al., 2004) and Dengue virus type 2 (Modis et al., 2004). Although the E 
proteins of TBE and Den viruses have less than 40% identical amino acids, the 
overall structures of both proteins are basically the same and it is assumed that 
this basic structure applies to all flavivirus E proteins.   
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2.3.3. Pre-fusion structure of E 
 
E is a glycoprotein of approximately 60 kD that is gently bent corresponding to 
the orientation of the metastable E dimer parallel to the viral membrane at 
neutral pH (Fig. 7 C, D). The two monomeric subunits are oriented antiparallel to 
each other and each monomer is organized in three distinct domains.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Ribbon diagrams (A, C) and schematics (B, D) of TBEV E proteins in their pre-
fusion conformations. (A, B) top view. (C, D) side view. Color codes: DI, red; DII, yellow; DIII 
blue; FP, orange; stem helices 1 and 2, light blue; C-terminal transmembrane helices, green; lipid 
membrane, grey (from Stiasny and Heinz, 2006). 
 
 
Domain I (DI) is the central domain composed of 120 residues and contains the 
N-terminus. Domain II (DII) is an elongated finger-like structure based on an 
antiparallel beta sheet of five short strands. Domain II is involved in most of the 
intersubunit contacts within the molecule (dimerization domain) and at its tip 
there is a highly conserved loop region that functions as internal fusion peptide 
(FP) (Allison et al., 2001). Within the dimer, the fusion peptide of one monomer 
is buried in a hydrophobic pocket between domains I and III (DIII) of the adjacent 
monomer and is thus protected from membrane-interactions in the native 
(A) 
(C) (D) 
(B) 
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conformation (Rey et al., 1995; Modis et al., 2003). DIII is an Ig-like domain 
containing the C-terminus of the truncated crystallized form (sE). The soluble sE 
proteins lack the last ~100 C-terminal amino acids (the so-called “stem-anchor 
region) and did not allow investigations of structural details beyond the end of 
DIII. Improved techniques for reconstructing cryo-EM images made it possible to 
determine these parts of E in their native conformation (Zhang et al., 2003a). 
The stem (~ 50 residues) connects the ectodomain with the transmembrane 
anchor. It contains two amphipathic helices that lie parallel to the viral membrane 
and are partially buried in it via hydrophobic interactions. The flavivirus E protein 
has a double membrane anchor consisting of two helices (Fig. 7 D). Also the M 
protein has two transmembrane regions, but it is assumed that there are no 
interactions between the transmembrane helices of E and M in the membrane 
(Mukhopadhyay et al., 2006).  
The junctions between the three domains are not rigid and allow hinge-like 
movements. Domains I and II are connected by four polypeptide chains, 
domains I and III by a single polypeptide linker (DI-DIII hinge) (Fig. 7 A) giving 
this region a flexibility that is important for particle maturation and membrane 
fusion (reviewed in Stiasny and Heinz, 2006).  
DIII has been discussed to contain a receptor binding site (Bhardwaj et al., 
2001). The receptors for flavivirus internalization have not yet been clearly 
identified. Most probably, there are general attachment receptors (like 
glycosaminoglycans), that can interact with various regions of E, contributing to 
specific receptor-DIII interactions. DC-SIGN and DC-SIGNR have been shown to 
be involved in the attachment of Dengue (Tassaneetripthep et al., 2003) and 
West Nile viruses (Davis et al., 2006) to immature dendritic cells. CD14 
associated molecules may be essential for Dengue virus entry (Chen et al., 
1997; Chen, Wang and King, 1999).  
 
 
2.3.4. Post-fusion structure of E 
 
In contrast to the native dimers, the low pH-induced post-fusion structures of the 
flavivirus fusion proteins are trimeric (Allison et al., 1995). While the antiparallel 
E dimers are oriented horizontally to the virus membrane (Fig. 7), the trimers are 
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oriented perpendicularly to it with the subunits arranged parallel to each other 
(Fig. 8). The structures of post-fusion sE trimers have been resolved for TBEV 
(Bressanelli et al., 2004) (Fig. 8 A) and for Dengue virus 2 (Modis et al., 2004), 
respectively. In the case of TBEV E these trimers have been shown to be 
significantly more thermostable than the E dimers (Stiasny et al., 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Ribbon diagram (A) and schematic (B) of E in its low pH-induced post-fusion 
conformation. Side view of sE (A) and the full-length E trimer (B). Color code corresponds to 
figure 7 above (from Stiasny and Heinz, 2006). 
 
 
In its post-fusion conformation E forms an elongated hairpin-like structure 
reminiscent of class I fusion proteins. As in class I proteins, the fusion peptides 
and the TM regions are juxtaposed at the same end of the molecule. It is largely 
unknown which conformation the stem adopts in the post-fusion structure 
because there is no structural data available on the full-length E trimer for any of 
the flaviviruses. The orientation of the C-terminus in sE, however, indicates that 
the stem follows grooves between the domains II alongside the trimeric core 
body (Bressanelli et al., 2004) (Fig. 8 B). The lack of a structure of the stem also 
leaves open the question if a cap-like structure is formed as in influenza fusion. 
The high hydrophobicity of the stretch of amino acids N-terminal of the TM 
domains would make interactions with the FPs plausible (Harrison, 2008b). 
 
 
 
(a) (b)
TM 2 Anchor
TM 1
FP
FP
(A) (B) 
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2.3.5. Low pH-induced transitions of E driving fusion 
 
The low pH-induced conversion from dimers to trimers requires the dissociation 
of the dimers into monomers and a subsequent reorganization into trimers. 
During the dimer-trimer transition the E protein domains retain their structural 
integrity (except some minor changes in DI), but have to rotate and rearrange 
with respect to each other (Fig. 9). There is a slight reorientation of DII due to a 
20° rotation at the DI-II junction. DIII, on the other hand, adopts a completely 
new position by relocating from the end to the side of the molecule, thereby 
bringing the C-terminus closer to the fusion peptide (reviewed in Stiasny and 
Heinz, 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Ribbon diagrams of TBE E monomers in their pre- (A) and post-fusion (B) 
conformations. Color code corresponds to figure 7. The arrows indicate the low pH-induced 
movements of domain III (blue arrow) and domain II (yellow arrow). Drawn with PyMol (DeLano, 
2002).  
 
 
These rotations are made possible by the built-in flexibility of the hinge 
structures between domains I-II and I-III. Certain mutations at the domains I-II 
interface altered the pH threshold for E mediated fusion, pointing out the 
importance of motion at this interface (Modis et al., 2003).  
C-ter
Domain I/II junction
Domain I/III linker Domain I/III linker
Fusion peptide
(A) (B) 
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The important role of the complete relocation of DIII is demonstrated by the fact 
that antibodies against DIII can inhibit viral entry after attachment (Nybakken et 
al., 2005) and that soluble DIII can act as a potent fusion inhibitor by binding to 
the polypeptide thus inhibiting the conformational changes described (Liao and 
Kielian, 2005). 
To allow the dissociation of the monomers and the movement of DIII, several 
contacts at the interface of DI and DIII must be broken. These interactions, 
including hydrogen bonds, van der Waals contacts and a prominent salt bridge, 
are thought to keep the native conformation of E in place (Fig. 10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Ribbon diagram showing contacts at a domains interface of native TBE E. 
Shown is the top view of the interface of the domains I and III in its pre-fusion conformation. 
Residues involved in interactions are labelled. Two conserved histidines (His146 and His323) 
and a conserved salt bridge (Arg9 and Glu373) are highlighted in light- and dark-grey and bold 
characters. For clarity residues 1-5 are not shown (Adapted from Bressanelli et al., 2004). Drawn 
with PyMol (DeLano, 2002). 
 
 
Fusion of some class I viruses is known to be inducible by unphysiological 
triggers – like heat – that lower the protein stability (Carr et al., 1997; Gibbons et 
al., 2000; Wharton, Skehel and Wiley, 2000; Wallin, Ekström and Garoff, 2005; 
Connoly et al., 2006). For class II proteins no such unspecific triggers were 
P360
T359
D149
R9
E373H146
F11
T325
W101
F108H323
D42
S40
I358
F371
R316
Y150
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identified (Gibbons et al., 2000; Stiasny et al., 2001), suggesting that the 
dissociation of the DI-DIII interface is tightly controlled and depends on the 
protonation of specific amino acids (Stiasny and Heinz, 2006). It has been 
proposed that protonation of key histidines within the domain interfaces is the 
trigger for the dissociation and the transitions described (Bressanelli et al., 2004; 
Kampmann et al., 2006). This issue is discussed in detail in chapter 3. 
 
 
2.3.6. Model of membrane fusion mediated by E 
 
Like for class I fusion proteins a hypothetical model of membrane fusion 
mediated by class II fusion proteins – represented by the flavivirus E protein in 
Figure 11 – has been developed. Most of the steps are still hypothetical and 
build on logical deductions based on the known structures of the initial and the 
end states. Evidence for the existence of monomeric pre-hairpin intermediates 
(Fig. 11 B) has been provided by the use of alkaline pH to trigger the initial 
phases of fusion (Stiasny et al., 2007a). 
The initiation of the fusion process requires the dissociation of the E dimers and 
the exposure of the FPs. The physiological trigger for these events is contact to 
low pH in the endosomes. Once dissociated, the monomeric subunits swing 
outwards and the exposed FPs insert into the target membrane (Fig.11 B), 
probably facilitating the subunit reorganization into trimers. It is not completely 
clear whether trimerization of the monomers occurs before the relocation of DIII 
(facilitated by insertion of the FPs), or afterwards probably as a consequence of 
it. Through the relocation of DIII the C-terminus moves close to the FP, a 
prominent hallmark of the post-fusion conformation. The stem is thought to zip 
up along the sides of domains II (Stiasny and Heinz, 2006; Harrison, 2008b). 
These conformational changes probably lead to the bending of the membranes 
involved (Fig.11 C). It is believed that fusion proceeds via a hemifusion 
intermediate, in which only the outer membrane leaflets have mixed 
(Chernomordik & Kozlov, 2005; Chernomordik, Zimmerberg and Kozlov, 2006; 
Harrison, 2008) (Fig.11 D). The final step is the formation of a fusion pore that 
allows the release of the nucleocapsid (Fig. 11 E).  
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Figure 11. Schematic model of the flavivirus membrane fusion process. (A): Side view of 
one – out of 90 – metastable E dimers at the surface of a flavivirus particle at neutral pH. The 
FPs are buried at an interface with DIII of the adjacent monomer. (B): Low pH-induced 
dissociation of the E dimer and interaction of the FPs with the target membrane. (C): E 
trimerization and initiation of hairpin formation. DIII relocates to the side of the molecule and the 
stem segment zippers up along the trimeric core body. (D): Formation of a hemifusion 
intermediate with only the outer leaflets mixed. (E): Formation of a fusion pore. Color code for E 
corresponds to the figures above. Color of the membranes: viral membrane blue, host cell 
membrane: grey (from Stiasny et al., 2007b). 
 
 
Class I and II viral fusion proteins display unrelated structures. Still they show 
the same principle of merging two membranes by leaving a state of metastability 
– by interactions with a host cell – and adopting a more stable “hairpin-like” post-
fusion conformation. This suggests that the underlying mechanisms of 
membrane fusion mediated by different fusion proteins are closely related 
(reviewed in Jardetzky and Lamb, 2004; Schibli and Weissenhorn, 2004; Kielian 
and Rey, 2006).  
 
 
H+H+ 
(A) (B) (C)
(D) (E)
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2.3.7. Differences and shared properties of the class II fusion systems of 
alpha- and flaviviruses 
 
The flavivirus class II fusion protein E has some unique characteristics, but it 
shares some features with the fusion protein E1 of the alphaviruses (reviewed in 
Stiasny and Heinz, 2006; Kielian, 2006). Figure 12 shows E1 of the alphavirus 
Semliki forest virus (SFV) in its pre-fusion (A) and post-fusion (C) conformations 
as well as a mature SFV particle at neutral pH (B) and conserved histidines in 
the E1 monomer in its pre-fusion conformation (D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. The E1 protein of Semliki forest virus. (A): Pre-fusion conformation of E1 (ribbon 
representation) in complex with E2 (represented as grey spheres). (B): Organization of E1 across 
the alphaviral surface (for clarity E2 is left out) (from Kielian and Rey, 2006). (C): Ribbon diagram 
of E1 in its pre-fusion conformation, showing the histidines in the monomer. Conserved residues 
are highlighted by boxes (from Roussel et al., 2006). (D): Post-fusion E1 trimer drawn with PyMol 
(DeLano, 2002). Color code for (A), (B) and (D) corresponds to the flavivirus E protein above. In 
(C) domain II is colored yellow and orange to differentiate DII loops, the fusion loop is brown. 
(a) (b)
(c) (d)
A) (B)
(C) (D) 
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One similarity between E and E1 is the organization of both proteins in three 
domains (DI, II, III) with an internal fusion loop at the tip of DII. Similar to E in 
flaviviruses, the E1 proteins of alphaviruses are organized as an icosahedral 
lattice in the envelope (Lescar et al., 2001; Pletnev et al., 2001) (Fig.12 B). Like 
the flavivirus fusion protein, E1 is synthesized as a complex with an accessory 
protein (prM in the case of flaviviruses, p62 for alphaviruses) that has chaperone 
activity, and protein maturation depends on cleavage of that protein by furin. 
Overall, the similar structural organization and topology of the domains of E and 
E1, including the location of the fusion peptides, suggests a common ancestor 
gene (Bressanelli et al., 2004).  
For both, the flavivirus E and the alphavirus E1 protein, the trigger for the 
irreversible formation of the post-fusion trimers is exposure to low pH. Like in E, 
conserved histidines in E1 at the interface of DI and DIII are discussed as 
potential proton-acceptors driving the destabilizing process causing fusion (Fig. 
12 C) (Roussel et al., 2006; Rey, 2008). The trimers of both class II proteins 
were observed to form rings of six (flaviviruses) or five to six trimers 
(alphaviruses) when formed in the presence of membranes, suggesting 
cooperativity between trimers during fusion (Gibbons et al., 2004; Stiasny et al., 
2004). 
Despite the mentioned similarities between alpha- and flaviviruses there are a 
number of important differences. E and E1 do not show any remarkable 
sequence homology. While E mediates both, receptor binding and fusion, E1 is 
monofunctional, i.e. it only mediates fusion. Receptor binding is mediated by E2, 
a second surface glycoprotein that forms a heterodimeric complex with E1 and is 
derived from cleavage of the precursor p62. In contrast to the smooth surface of 
flaviviruses the surface of alphaviruses displays spikes formed by eighty trimers 
of E1/E2 heterodimers (Zhang et al., 2002; Mukhopadhyay et al., 2006).  
 Even though a partner protein is cleaved as in flavivirus maturation, the cellular 
maturation pathway of alphaviruses is different because they bud at the plasma 
membrane, and not at the endoplasmatic reticulum. 
Another major difference between the two fusion proteins is the protection of the 
fusion peptides. In flavivirus E, the FP is shielded by prM before virus maturation 
and after maturation cleavage it is hidden in a hydrophobic pocket within the E 
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dimer. In the case of alphaviruses, the fusion peptide is shielded by E2 in both, 
the immature and the mature forms.  
The alphavirus E1 trimer has an open tip, formed by domains II (Fig. 12) 
(Gibbons et al., 2004) which is in contrast to the closed tip conformation of 
trimeric E (Fig. 8).  
Flavivirus E is anchored in the viral membrane by a double membrane anchor 
composed of two transmembrane domains. E1 has a single membrane-spanning 
helix instead.  
Flaviviruses profit from cholesterol in the target membrane, because it enhances 
fusion peptide insertion and trimerization of E (Stiasny, Koessl and Heinz, 2003). 
In contrast, alphaviruses are absolutely dependent on the presence of 
cholesterol as well as sphingomyelin for efficient fusion (Wahlberg et al., 1992; 
Kielian et al., 2000).  
Nevertheless, the structural similarity of E and E1 in their pre- as well as in their 
post-fusion conformations suggests that the overall fusion process for flavi- and 
alphaviruses is very similar. 
 
 
2.4. A third class of viral fusion proteins 
 
Recently the crystal structures of the HSV1 glycoprotein B (Heldwein et al., 
2006) in its post-fusion conformation and of the VSV glycoprotein G in its neutral 
pH (pre-fusion) and low pH (post-fusion) conformations have been resolved 
(Roche et al., 2006; 2007). Based on their structural characteristics, these fusion 
proteins have been proposed to form a third class of viral fusion glycoproteins. 
The baculovirus gp64 glycoprotein fits into this class as well (Garry and Garry, 
2008; Kadlec, 2008; Kadlec et al., 2008). In contrast to the proteins discussed so 
far, it has been shown for VSV G that the pH-induced shift between the 
conformational states is reversible (Roche and Gaudin, 2002; reviewed in Roche 
et al., 2008). 
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2.4.1. The Vesicular stomatitis virus (VSV) G protein 
 
Vesicular stomatitis virus belongs to the family Rhabdoviridae, whose members 
are enveloped viruses with a bullet shaped structure. Cell entry, occuring via the 
endocytic pathway and low pH-triggered fusion with the endosomal membrane, 
is driven by the trimeric glycoprotein G. Before structures of G were determined, 
it was already known from biophysical and biochemical investigations that VSV 
G can adopt various conformational states (Gaudin et al., 1993): the native state 
(at neutral pH) which in contrast to class I and II fusion proteins is not 
metastable, an activated state interacting with target membranes and a post-
fusion state that is antigenically different from the native and the activated state 
(Roche and Gaudin, 2002). There is a pH-dependent equilibrium between the 
conformations and the low pH-induced structural alterations are reversible which 
is different from the other two classes of fusion proteins. This reversibility is 
necessary to recover the neutral pH structure of G after the transport of the virus 
particles through the acidic Golgi apparatus during particle export (reviewed in 
Gaudin, 2000; Roche et al., 2008). The existence of a low pH, fusion-inactive 
state replaces the need for the chaperone molecules found in the class II 
systems (prM and p62) (Gaudin et al., 1995). After particle release, G adopts its 
native conformation which is depicted in Figure 13. In this neutral pH form, the 
fusion protein shows the shape of a tripod with the fusion loops pointing towards 
the viral membrane (Roche et al., 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Ribbon diagram of VSV G in its pre-
fusion conformation. Color code: DI, red; DII, blue; 
DIII, orange; DIV yellow; FPs, green; C-terminus, 
magenta. The close-up view shows a network of 
conserved residues (note the cluster of conserved 
histidines) between domains III and IV described closer 
in chapter 3 (Adapted from Roche et al., 2007). 
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The monomeric subunits within this pre-fusion trimer consist of four domains (DI-
IV). Domain I – the central domain (red in Fig. 13) – and domain II – a relatively 
long alpha helix (blue in Fig. 13) – build most of the intersubunit contacts in the 
trimer. The fusion domains (DIV, yellow in Fig. 13) are set apart to separate the 
fusion loops that are not buried within an oligomeric structure as in class I and II 
fusion proteins. The subunits of the fusion proteins of the other class III 
members (HSV gB and baculovirus gp64) consist of five domains each. 
Figure 14 C shows the structure of the glycoprotein G in its low pH (the post-
fusion) form compared to class I (A) and class II (B) fusion proteins. In this fully 
rearranged low pH conformation G displays the classical hairpin conformation. 
There is a central alpha helical coiled coil (DII, colored blue) like in class I 
proteins. The C-terminal parts have zipped up along the fusion domains (DIV), 
similar to the fusion-related transition in flavivirus E. Each chain possesses 
bipartite fusion loops at the tip of an elongated beta sheet (domain IV) which is 
also comparable – but not homologous – to the situation with class II proteins. 
 
 
 
 
Figure 14. Structural motifs of viral membrane fusion proteins. Ribbon diagrams of 
representative structures of class I, II and III viral fusion proteins, (A) gp-41 of HIV1, (B) 
flavivirus glycoprotein E, (C) VSV glycoprotein G, in their post-fusion conformation (Adapted 
from Weissenhorn, Hinz and Gaudin, 2007). 
  
(A) (B) (C)
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Based on the knowledge of these structures of VSV G, the conformational 
changes rearranging the neutral pH form (the tripod) to the low-pH form were 
reconstructed (reviewed in detail in Roche et al., 2007; 2008). Domains I, III and 
IV retain their tertiary structure, but undergo large rearrangements in their 
relative orientation towards each other caused by changes in the hinge regions 
between domains III and IV. Domain II, the central domain, has to undergo major 
refolding to contribute to the formation of the post-fusion conformation. There is 
a loop to helix transition between DIV and DII creating an extended coiled coil at 
the trimer centre (DII, Fig. 14 C), reminiscent of the formation of the extended 
intermediate coiled-coil structure described for influenza HA. The part of domain 
II that remains unchanged, together with domain I, forms a rigid block that is the 
linchpin for flipping domain IV and a C-terminal segment which is the main 
movement of the transitions leading to the post-fusion conformation. 
Refolding of G displays certain similarities to the other classes of fusion proteins. 
As addressed, the elongation of the central helices is a hallmark of the 
transitions driving class I fusion. Because of the great differences between the 
pre- and post-fusion conformations of G, it is possible that the whole transition 
process includes a transient monomeric intermediate like in class II protein 
mediated fusion. The low pH structure of VSV G is missing the “stem-anchor” 
region, but the C-terminal end of the truncated protein is oriented towards the 
fusion domain (Fig. 14 C). Therefore the fusion loops and the anchor elements 
must be in close vicinity at the same end of the trimer, suggesting hairpin 
formation similar to class I and II fusion proteins. A recent report compared 
structural motifs within the domains of class I, II and III fusion proteins and – 
because of the existence of structural counterparts – suggested that all three 
classes are more related than generally assumed (Kadlec et al., 2008). 
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3. pH sensors in virus membrane fusion 
 
 
 
The fusion proteins of viruses that enter cells via endocytosis sense the local 
proton concentration in endosomes and carry out membrane fusion in response 
to acidic pH. There are also numerous cellular processes that involve pH 
sensors (reviewed in Srivastava, Barber and Jacobson, 2007). Proton binding is 
extremely fast and can drive changes in protein structure, dynamics and 
interactions. A classical example of a proton-induced protein modification is the 
hemoglobin Bohr effect (reviewed in Riggs, 1988). The affinity for oxygen in 
human hemoglobin can be controlled by a salt bridge built by His146 and Asp94, 
which is broken upon deprotonation of the histidine at increased pH. The pH-
dependent modification of histidines has further been reported to be the cause of 
structural changes in unrelated proteins and protein complexes (for example 
Ingram-Smith, Barber and Ferry, 2000; Nordlund et al., 2003; Lee et al., 2005; 
Nyarko et al., 2005; Astier, Bayley and Howorka, 2005; Day et al., 2006; Hu et 
al., 2006; Perrier et al., 2007).  
Many viral fusion proteins become activated at pH ranges close to the pKa of 
histidines (6.5, although the effective pKa of a specific residue depends on its 
environment). Therefore a “histidine switch hypothesis” was developed, 
suggesting that – for some viruses – protonation of conserved histidine residues 
might be the trigger for membrane fusion (Bressanelli et al., 2004; Roussel et al., 
2006; Kampmann et al., 2006; Mueller et al., 2008; Roche et al., 2008). 
Experimental evidence for this hypothesis is, however, still lacking. 
 
 
3.1. Histidines as putative pH sensors in the influenza HA  
 
Protonation of histidines in influenza HA has been proposed to play a role for 
initiating the membrane fusion process (Chen et al., 1988; Stevens et al., 2004; 
Kampmann et al., 2006) 
Recent studies tested HA mutants for their pH requirements to undergo the 
structural alterations necessary for mediating fusion (Steinhauer et al., 1996; 
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Thoennes et al., 2008). Among these, a histidine to tyrosine mutation in residue 
17 of HA1 led to a decrease of the pH threshold for structural changes and 
membrane fusion compared to the wild-type. It was therefore hypothesized that 
protonation of H17 is triggering HA-mediated fusion (Thoennes et al., 2008). 
H17, however, is only partially conserved but it is located close to other 
histidines (H18, H37, H106 and H111) and these residues may also 
cooperatively regulate the process. The latter hypothesis is supported by the fact 
that histidine mutations in influenza HA shifted the pH-dependence of fusion but 
did not abolish the process completely. Furthermore it was demonstrated that 
mutations (including mutations of H17 to arginine and glutamine) at trimer 
interfaces – that break during the rearrangements – also shifted the pH threshold 
for fusion but by affecting the trimer stability (Daniels et al., 1985). 
In the case of influenza HA it seems that the conformational changes are 
triggered by a cumulative effect of positive charges resulting from unspecific 
protonation of a number of amino acids.  
 
 
3.2. The role of histidines in the flavivirus fusion protein E 
 
There are five conserved histidines in flavivirus E and because of the pH 
threshold of flavivirus fusion (6.6) they are plausible pH sensor candidates. Two 
are located at the interface of DI and DIII (H146 and H323 in TBEV E), one at 
the domains I-II interface (H287 in TBEV), one in DII (H248 in TBEV) and one in 
the stem (H438 in TBEV) (Fig. 15). The precise role of these residues in the 
membrane fusion process has not been investigated so far.  
Especially the protonation of H146 and H323 in TBEV E – equivalent to H144 
and H317 in E of DENV2 – has been discussed as trigger mechanism for 
flavivirus fusion (Bresanelli et al., 2004; Harrison 2008b). These histidines are 
not only located in strategic key positions, but they also interact with residues in 
their vicinity to clamp the structure in the pre- or the post-fusion form. At neutral 
pH, they interact with positively charged residues (lysines and arginines) in their 
vicinity. Upon protonation they become positively charged themselves. Their 
new charge is thought to destabilize the pre-fusion interactions and leads to the 
formation of salt bridges with negatively charged residues (aspartatic and 
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glutamic acids). These new interactions probably stabilize the post-fusion 
structure (Kampmann et al., 2006). Structure analysis revealed that in the pre-
fusion dimer histidines 146 and 323 are both most likely to interact with arginine 
9 of the prominent interdomain salt bridge between domains I and III (Fig. 10). In 
the post-fusion conformation, H146 forms a new interaction with the conserved 
residue D42 of domain I. H323 on the other hand interacts with E373, the other 
part of the salt bridge connecting DI and DIII in the pre-fusion structure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Conserved histidines in the TBEV E pre-fusion dimer. Shown are ribbon diagrams 
of the E dimer in top (upper part) and side view (lower part). The side view contains a schematic 
representation of the parts for which the aromic structure is not known. The histidines conserved 
among all flavivirus E proteins are labelled and highlighted as grey spheres. Color code 
corresponds to figure 7. Drawn with PyMol (DeLano, 2002). 
 
 
Alphavirus fusion may be triggered by histidine protonation as well (Roussel et 
al., 2006) (Fig. 12), but there is only one conserved histidine at a position 
homologous in flavivirus E and alphavirus E1. This histidine (H248 in E and 
H230 in E1, respectively) was shown to be involved in a late stage of E1 
mediated fusion of Semliki forest virus but not in the initial stages nor in trimer 
HIS 146HIS 248 HIS 323
HIS 438
HIS 287
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formation (Chanel-Vos and Kielian, 2004). These results indicate that the 
residues involved in triggering alphavirus fusion are located elsewhere, probably 
between E1 domains I and III.  
Conserved histidines could also be involved in other pH-dependent processes 
than fusion. The flavivirus membrane protein precursor prM protects the fusion 
protein in the TGN from early activation (see chapter 2.3.1.). The maturation 
cleavage of prM requires low-pH. The exposure of the furin cleavage site of prM 
relies on structural alterations in the prM/E complex that may also be induced by 
the protonation of histidines. After the cleavage, pr stays associated with E until 
it encounters neutral pH conditions in the extracellular environment. The recently 
resolved structure of prM of dengue 2 shows, that E residue histidine 244 – 
corresponding to conserved H248 in domain II of TBE E (Fig. 17) – is most likely 
interacting with the acidic residue D63 of prM (Li et al., 2008). This interaction 
may be responsible for the attachment of cleaved pr and the deprotonation of 
histidine 244 may be a prerequisite for releasing the pr peptide after virus 
secretion (Li et al., 2008; Yu et al., 2008) 
 
 
3.3. pH-sensitive molecular switches in the VSV G protein 
 
In the class III fusion protein G of VSV, conserved residues were identified that 
seem to act as molecular switches for initiating the reversible structural changes 
described in chapter 2.4.1. (Roche et al., 2007): Conserved histidines in the pre-
fusion conformation and acidic amino acids in the post-fusion conformation 
constitute two separate pH-sensitive switches. Specifically, three conserved 
histidines in VSV G have been discussed to form a cluster of positive charges 
upon protonation that might trigger the structural changes leading from the pre- 
to the post-fusion conformation (Roche et al., 2008). These histidines (shown in 
the close up view in Figure 13) are residues 60 and 162 in domain IV and 407 in 
the C-terminal part. So far, there is no experimental evidence for their 
contribution to the low pH-induced structural alterations, but it was shown that 
treatment with diethylpyrocarbonate (DEPC) inhibits G-mediated VSV 
membrane fusion by unspecifically preventing the protonation of all histidine 
residues in the molecule (Carneiro et al., 2003). 
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In the low pH (the post-fusion) conformation, acidic residues of G (D268, D274, 
E276, D393 and D395) are brought into close approximity in a central bundle 
formed by the helices of domain II of G (Fig. 14). The low pH conformation is 
presumably adopted in the TGN during VSV particle exocytosis from the host 
cell. When the particles encounters neutral pH conditions after the release from 
the cell, the deprotonation of these amino acids is thought to destabilize the 
trimer and initiate the refolding towards the tripod-like pre-fusion state.  
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II. OBJECTIVES 
 
 
 
The overall goal of this PhD thesis was to gain new insights into the structural 
and functional requirements of flavivirus membrane fusion by the introduction of 
mutations and truncations into the E protein of recombinant subviral particles 
(RSPs) of tick borne encephalitis virus (TBEV). 
Specifically, two aspects were investigated: (I) the “histidine switch” hypothesis 
was experimentally tested for the first time in a class II viral fusion system and 
(II) the functional role of the membrane anchor of E in different stages of fusion 
was explored. An essential part for both subprojects was the establishment of 
quality controls of subviral particles to verify their maturation state and structural 
integrity. 
 
 
Specific aims 
 
I.  Investigation of the role of specific histidines in flavivirus membrane 
fusion 
 
It was the specific goal of the first part of my thesis to dissect the structural basis 
of the low pH trigger for flavivirus membrane fusion. Five histidines are 
absolutely conserved among all flavivirus E proteins and – because of their pKa 
– have been hypothesized to function as molecular pH sensors for initiating 
fusion (see chapter 3.2.). To directly investigate the role of all conserved 
histidines in E for acidic pH-mediated fusion, I used a mutagenesis approach 
and substituted them in RSPs of TBEV. The mutant RSPs were investigated for 
their ability to undergo low pH-mediated E dimer dissociation, target membrane 
binding, E trimerization and lipid mixing.  
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II. Dissection of the functional role of the second transmembrane helix of 
the flavivirus fusion protein 
 
The purpose of the second part of the thesis was to contribute to the 
understanding of a so far not very well characterized part of the flavivirus fusion 
protein: the membrane anchor that is absent in the crystallographic structures of 
truncated E proteins. 
The single transmembrane domains of several viral fusion proteins have been 
shown to be crucial for the late steps of membrane fusion and are thought to be 
essential for the hemifusion to fusion transition (Kemble et al., 1994; Melikyan, 
White and Cohen, 1995; Melikyan et al., 1997; Armstrong, Kushnir and White, 
2008; reviewed in Schroth-Diez et al., 2000; Langosch, Hofmann and 
Ungermann, 2007). The role of the double membrane anchor of the flavivirus E 
protein has not been investigated so far.  
C-terminally truncated E proteins – that lack the second transmembrane domain 
(TM2) – were investigated in subviral particles to clarify whether – and at which 
stage of the process (Binding, E dimer dissociation, E trimerization) – the second 
TM domain is essential for flavivirus fusion.  
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The editors of the Journal of Cell Biology and of the Journal of 
Experimental Medicine highlighted the publication 
 
Flavivirus reveals its access code 
Ruth Williams The Journal of Cell Biology, Vol. 183, No. 2, 172. 
Fritz et al. have identified an amino acid switch that flaviviruses flip to gain 
access to cells.  
Flaviviruses such as tick-borne encephalitis virus (TBEV), yellow fever, and 
dengue are dangerous human pathogens. These membrane-encircled viruses 
enter cells by being gobbled up into endosomes and fusing their membrane with 
that of the endosome.  
Fusion is triggered by the endosome's acidic environment. Low pH prompts the 
aptly named fusion protein, on the virus's outer membrane, to change shape and 
grab hold of the endosome membrane, bringing the two membranes together. In 
their search for possible pH sensors, researchers have focused on five highly 
conserved histidine residues in the flavivirus fusion protein. The chemical 
properties of histidines make them prime candidates—they switch from 
uncharged to having a double positive charge upon acidification of their 
environment, such as that in endosomes.  
Fritz et al. replaced each of the five histidines of the TBEV fusion protein with 
alternative residues and observed the virus's fusion ability. Given the 
conservation of the five histidines, the team was surprised, that mutation of one 
of the histidines, His323, was sufficient to completely abolish fusion. Individual 
mutation of three of the others had no effect on fusion whatsoever, and mutation 
of the fourth led to an untestable ill-formed fusion protein. The team went on to 
show that mutation of the crucial His323 interfered with the pH-induced shape 
change of the fusion protein.  
 
 
 
 
 
The fusion protein (yellow, red, 
blue) on the viral membrane 
(pale blue) changes shape at 
low pH and attaches to the 
endosome membrane (gray). 
The pH sensor for this first 
step of fusion is His323. 
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1.1. Abstract 
 
 
The flavivirus membrane fusion machinery - like that of many other enveloped 
viruses – is triggered by the acidic pH in endosomes after virus uptake by 
receptor-mediated endocytosis. 
It has been hypothesized that conserved histidines in the class II fusion protein E 
of these viruses function as molecular switches and, by their protonation, control 
the fusion process. Using the mutational analysis of recombinant subviral 
particles of tick-borne encephalitis virus, we provide direct experimental 
evidence that the initiation of fusion is crucially dependent on the protonation of 
one of the conserved histidines (His323) at the interface between domains I and 
III of E, leading to the dissolution of domain interactions and to the exposure of 
the fusion peptide. Conserved histidines located outside this critical interface 
were found to be completely dispensable for triggering fusion. 
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1.2. Introduction 
 
 
The entry of enveloped viruses into host cells involves a fusion step between the 
viral and a cellular membrane. This process is mediated by viral fusion proteins 
that are associated with the viral membrane and primed to undergo structural 
rearrangements that drive fusion (Kielian and Rey, 2006; Weissenhorn et al., 
2007; Harrison, 2008; White et al., 2008). These conformational changes are 
activated by specific triggers, allowing fusion to occur at the right time and at the 
right place in the viral life cycle. Different trigger mechanisms (and combinations 
thereof) have been identified, including (a) interactions with cellular receptors, 
leading to fusion at the plasma membrane, and (b) protonation by the acidic pH 
in endosomes, leading to fusion from within endosomes after virus uptake by 
receptor-mediated endocytosis (White et al., 2008). In the latter case, like in 
other protein systems of intracellular pH sensors (Srivastava et al., 2007), 
histidines have been discussed to play a key role as molecular switches 
because their protonation state changes from uncharged to doubly positively-
charged at the slightly acidic pH found in endosomes (Carneiro et al., 2003; 
Bressanelli et al., 2004; Stevens et al., 2004; Kampmann et al., 2006; Kanai et 
al., 2006; Roussel et al., 2006; Mueller et al., 2008; Roche et al., 2008; 
Thoennes et al., 2008). 
So far, two structurally unrelated classes of viral fusion proteins have been 
identified (class I in myxo-, paramyxo-, retro-, filo-, and coronaviruses; class II in 
alpha- and flaviviruses) (Kielian and Rey, 2006), together with a third class that 
combines features of both class I and class II (rhabdo- and herpesviruses; 
Weissenhorn et al., 2007; White et al., 2008). They all comprise representatives 
that are triggered by acidic pH. Despite the knowledge of atomic structures from 
all three protein classes (Weissenhorn et al., 2007; Harrison, 2008; White et al., 
2008), it proved difficult, both in experimental and molecular simulation 
approaches, to conclusively answer the question whether the initial trigger for 
destabilization and conformational changes is provided by the protonation of 
individual histidine residues, by combinations thereof, or by a cumulative effect 
through the increase of positive charge (Kampmann et al., 2006; Mueller et al., 
2008; Thoennes et al., 2008).  
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In class II fusion proteins, the molecular sensors for triggering fusion have not 
yet been identified. We therefore conducted a study in a prototypic class II fusion 
protein system (the flavivirus tick-borne encephalitis virus [TBEV]) and provide 
experimental evidence that the protonation of a specific histidine plays a key role 
for the destabilization of an intramolecular interface in the fusion protein and thus 
allows the initiation of the fusion process. 
Flaviviruses (genus Flavivirus and family Flaviviridae) have an acidic pH-
dependent fusion machinery (Stiasny and Heinz, 2006) and comprise several 
closely related important human pathogens, including yellow fever, dengue, 
Japanese encephalitis, West Nile, and TBE viruses (Gubler et al., 2007). The 
surface of mature flaviviruses is made up of a herringbone-like assembly of 90 
homodimers of the E protein (Kuhn et al., 2002; Mukhopadhyay et al., 2003). 
The atomic structures of soluble forms of E (sE), lacking the membrane anchor 
and the so-called ‘stem’ (Fig. 1B), have been determined for different flaviviruses 
in pre- and post-fusion conformations (Fig. 1, B and C; Rey et al., 1995; Modis et 
al., 2003, 2004, 2005; Bressanelli et al., 2004; Zhang et al., 2004; Kanai et al., 
2006; Nybakken et al., 2006). In the pre-fusion conformation, the internal fusion 
peptide (FP) loop at the tip of domain II (DII) is buried through the interaction 
with a hydrophobic pocket provided by DI and DIII of the second partner in the 
homodimer (Fig. 1 B). Exposure to acidic pH leads to the initiation of the fusion 
process as depicted in Fig. 1 D. 
Five histidine residues, located in DI, II, and III as well as in the 'stem' region 
(Fig. 1, B and C), are conserved among all flavivirus E proteins and their function 
as pH sensors in flavivirus fusion has been discussed (Bressanelli et al., 2004; 
Kampmann et al., 2006; Kanai et al., 2006; Nybakken et al., 2006; Mueller et al., 
2008). To support this hypothesis experimentally, we used recombinant subviral 
particles (RSPs) of TBEV as a model and targeted the conserved histidines in a 
mutational approach. As shown previously, RSPs are excellent tools for studying 
flavivirus fusion because they contain a lipid membrane, carry the E protein in a 
conformation that is indistinguishable from that on the virus and, most 
importantly, display fusion characteristics similar to those of infectious virions ( 
Schalich et al., 1996; Corver et al., 2000). This system allowed us to study the 
effect of histidine replacements on the different steps of fusion in the absence of 
resuscitating mutations that would occur during virus replication. 
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In our work, we demonstrate that His323, located at the interface of DI and III in 
the pre-fusion conformation of E, has a crucial function as a pH sensor for 
initiating fusion. Surprisingly, 3 of the 5 conserved histidines in E were shown to 
be completely dispensable for the early phases of fusion but two of these 
residues appeared to contribute to the overall stability of the post-fusion trimer. 
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Figure 1. Summary of the organization of flavivirus particles, the three-dimensional 
structures of the flavivirus envelope protein E, and a model of flavivirus membrane 
fusion. (A) Schematic diagram of a flavivirus particle in its immature (prM-containing) and 
mature form after proteolytic cleavage of prM. (B) Schematic of the pre-fusion E dimer including 
ribbon diagrams of the TBEV sE ectodomain (top and side view) and those parts for which the 
atomic structure is not known (stem and anchor). (C) Ribbon diagram of the post-fusion TBEV sE 
trimer (side view). The positions of the histidines conserved in all flavivirus E proteins are 
indicated by grey balls. (D) Schematic of the proposed flavivirus fusion mechanism showing 
different steps of the fusion process. (step 1) Metastable E dimer in mature virions. (step 2) 
Dissociation of the E dimers at acidic pH, outward projection of E monomers, and interaction of 
the FP with the target membrane. (step 3) Trimerization, DIII relocation, and “zipping up” of the 
stem. (step 4) Formation of the post-fusion trimer and opening of the fusion pore. Red, DI; 
yellow, DII; blue, DIII; orange, FP; purple, stem (linker between DIII and the transmembrane 
anchors); gray, transmembrane anchors. 
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1.3. Results 
 
 
1.3.1. Generation of RSPs with mutated His residues 
 
The RSPs of TBEV used in this study display similar fusion characteristics as 
infectious virions and are assembled in eukaryotic cells after transfection with 
plasmids that coexpress prM and E. Their maturation and secretion pathway 
follows that of whole virions, including the cleavage of prM in the trans-Golgi 
network to yield mature and fusion-active particles (Schalich et al., 1996). To 
obtain specific information on the molecular pH sensors of fusion, we replaced 
each of the five absolutely conserved histidines (and combinations thereof) in 
the E protein of RSPs by alanine or other amino acids and investigated their 
effect on fusion and fusion-related properties. Any mutation introduced into this 
system can potentially also interfere with processes unrelated to fusion, such as 
proper protein folding, oligomerization, particle formation, intracellular transport, 
protein processing, maturation and secretion of RSPs. We therefore performed a 
meticulous analysis of the mutant RSPs to ensure that the amino acid 
substitutions had not influenced their wild-type (WT)-like properties at neutral 
pH. This was accomplished by a series of quality control measures, including an 
analysis of the amount of RSPs secreted from transfected cells, the 
sedimentation behavior in sucrose gradients, the extent of maturation cleavage 
of prM, the oligomeric state of E, and the reactivity of the RSPs with a panel of 
22 monoclonal antibodies (mAbs). These mAbs recognize epitopes in each of 
the three domains of the mature E protein and have proven to be excellent tools 
for measuring conformational differences or changes (Heinz et al., 1994; Allison 
et al., 1995, 2001; Stiasny et al., 2005). 
To replace the histidines, we used alanine as a first choice, but, if an alanine 
mutation did not yield RSPs conforming to all of the criteria listed in the previous 
paragraph, other amino acids were substituted. Table 1 displays those single 
and combination mutants that passed all of the quality controls and were 
selected for the analyses described in this work. As can be seen from the table, 
WT-like RSPs were obtained with mutations at four of the five positions of 
conserved histidines, in two cases with alanine and in two cases with asparagine 
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substitutions. The exception was His146; in this case replacement by any of the 
other 19 amino acids resulted in the abolition of proper RSP formation and/or 
secretion (Table S1, available at http://www.jcb.org/cgi/content/full/jcb.200 
806081/DC1). 
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1.3.2. Fusion activity of His mutant RSPs 
 
Having certified that the replacement of histidines by other amino acids had not 
changed the overall conformation of E and its oligomeric state (nor did it impair 
particle formation, maturation, or secretion), we analyzed the effect of these 
mutations on fusion activity. For this purpose, the membranes of each of the 
mutant RSPs were fluorescence labeled in vivo with 1- pyrenehexadecanoic acid 
and subjected to an in vitro fusion assay (see Materials and methods). These 
RSPs were mixed with unlabeled liposomes and the decrease in pyrene excimer 
fluorescence (caused by dilution of the probe in the target membrane) was 
continuously monitored. Consistent with previous results (Corver et al., 2000), 
WT RSPs fused rapidly at pH 5.4 within the first seconds after acidification (Fig. 
2 A), and the fusion activities of mutants lacking a histidine residue at position 
248, 287 or 438 were identical to that of the wild-type (Fig. 2 B). The 
replacement of His323, however, resulted in the loss of fusion activity (Fig. 2, A 
and B) even at pH 5.0 (not depicted). We also analyzed combinations of 
mutations that alone did not affect fusion, i.e. H248N+H287A, H248N+H438N, 
and H287A+H438N. Unexpectedly, one of these combinations (H248N+H287A) 
impaired fusion to the same extent as did the replacement of His323 (Fig. 2, A 
and B). These experiments revealed the importance of individual conserved 
histidines for E-mediated fusion, but it remained unclear at which stage or how 
certain residues were involved in this multistep process. 
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Figure 2. Fusion activity of pyrene-labeled WT and mutant RSPs with liposomes at acidic 
pH. (A) Kinetic fusion curves of RSP WT (red) and the mutant RSPs H323A (orange) and 
H248N-H287A (blue) at pH 5.4. (B) Extent of fusion after 60 s of mutant RSPs relative to that of 
the WT (set at 100%). The experiments with those mutants that were significantly different from 
the WT were performed at least twice and the error bars represent the standard errors of the 
means. 
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1.3.3. Effect of His mutations on fusion peptide exposure 
 
It was the primary hypothesis of our work that histidines play a role as pH 
sensors and that their protonation would be the initial trigger for fusion. To 
analyze the very first step of the fusion process, we made use of an FP-specific 
mAb (A1) and developed an assay that allowed us to measure the acidic pH-
induced disengagement of the FP from its protecting interactions in the E dimer 
and its exposure to the environment. In previous experiments, we had found that 
during conversion of E from the pre-fusion dimer to the post-fusion trimer the 
accessibility of the FP for mAb A1 was transiently increased but lost upon 
conversion into the final trimeric conformation (Stiasny et al., 2007). We 
therefore measured this transient FP exposure using an enzyme immunoassay 
in which the antibody was already present in the RSP samples at the time of 
their acidification (see Materials and methods). The results of these experiments 
are shown in Fig. 3. With the exception of mutant H323A, none of the three other 
single His mutants differed significantly from the WT, neither with respect to the 
extent nor to the pH threshold of FP exposure (unpublished data). The same 
holds true for the double and triple mutants, which all displayed a WT-like 
pattern (Fig. 3). In contrast, FP exposure was severely impaired in the case of 
the H323A mutant, but the residual activity was induced at the same pH 
threshold as with the WT, i.e. around pH 6.6 (Fig. 3). These results allow us to 
conclude that of the four histidines analyzed only His323 plays an important role 
as an initial fusion trigger and that the lack of fusion activity observed with the 
double mutant H248N-H287A was caused by an impairment of later steps of 
fusion. 
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Figure 3. Acidic pH-induced FP exposure as measured by the binding of the FP-specific 
mAb A1. Results are expressed as a percentage of the maximal reactivity of A1 obtained with 
the WT at pH 5.4. The data are the means of three independent experiments performed in 
duplicate; the error bars represent the standard errors of the means. 
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1.3.4. Loss of membrane interactions by His mutations 
 
According to the proposed scheme of flavivirus membrane fusion (Fig. 1 D), the 
exposure of the FP allows its interaction with target membranes and thus 
mechanistically initiates the fusion process. To assess whether the observed FP 
exposure indeed correlated with the proposed functional activity, we performed 
liposome coflotation experiments for measuring membrane binding. Preparations 
of WT and His mutant RSPs were mixed with liposomes, acidified, and applied 
to sucrose step gradients as described in Materials and methods. Coflotation of 
E to the top of the gradients indicates either binding to or fusion with liposomes. 
The results of these experiments as depicted in Fig. 4 precisely matched those 
of the FP exposure assay (Fig. 3). With the exception of the severely impaired 
mutant H323A, all of the other single and combination mutants displayed the 
same acidic pH-induced coflotation behavior as the WT. Because the double 
mutant H248N-H287A was completely fusion negative (Fig. 2), we made sure 
that its unimpaired coflotation was indeed only caused by binding to the 
liposomes, in the absence of fusion. For that purpose, coflotation assays were 
performed with pyrene-labeled samples of the mutant and WT RSPs, and 
fluorescence emission spectra were recorded with the coflotated fractions. In the 
case of RSP H248N-H287A, a strong pyrene excimer peak (which equals no 
dilution of the fluorescence probe) was observed, whereas it was strongly 
reduced with coflotated WT RSPs (Fig. 4, C, inset). These results thus allowed 
the unambiguous conclusion that the coflotation with the double mutant, in 
contrast to that of the WT, was caused by an interaction with liposomes in the 
absence of fusion activity. 
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Figure 4. Acidic pH-induced coflotation of WT and mutant RSPs with liposomes. RSPs 
were incubated with liposomes at pH 5.4 (solid lines) and pH 8.0 (dotted lines), back-neutralized, 
and then subjected to centrifugation in sucrose step gradients. The gradients were fractionated, 
and the amount of E protein in each fraction was determined by a quantitative four-layer ELISA. 
The top fractions containing RSPs coflotated with the liposomes are indicated by a bracket. (A-C) 
Representative examples of the analysis of the step gradients obtained with WT (A) and the 
fusion-negative mutants H323A (B) and H248N-H287A (C). The inset in C shows the 
fluorescence spectrum of the coflotated fractions of the mutant (gray) relative to those of the WT 
(black) from experiments using pyrene-labeled RSPs. AU, arbitrary units. (D) Extent of acidic pH-
induced coflotation of E with liposomes obtained with mutant RSPs relative to the WT (set at 
100%). The data are the means from at least two independent experiments; the error bars 
represent the standard errors of the means. 
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1.3.5. Impairment of the formation and stability of E trimers 
 
The results obtained so far indicated that only His323, but none of the other 
histidines investigated, was involved in the initiation of fusion. We therefore 
hypothesized that the lack of fusion observed with the double mutant H248N-
H287A was due to an impairment of later steps, such as the formation and/or 
stability of the E trimer. We addressed this question by sedimentation analyses 
and investigated the effect of each of the His mutations on the acidic pH-induced 
conversion of E dimers into trimers. Like with the WT RSPs, a quantitative E 
dimer to trimer transition was observed with the single mutants H248N, H287A, 
and H438N, as well as with the double mutants H248N-H438N and H287A-
H438N (Fig. 5, A and B; and not depicted). In contrast, trimer formation was 
impaired with H323A and H248N-H287A (Fig. 5, C and D). Similar to the 
situation found with the pH dependence of FP exposure (Fig. 3), the pH 
threshold for the oligomeric rearrangement was identical to the WT with all of the 
mutants (pH 6.6), irrespective of the amount of trimers formed (Fig. 6). 
Because the mutations introduced into E may not only influence the formation of 
trimers but also their stability, we performed thermal denaturation experiments 
as follows. RSPs were acidified, back-neutralized, solubilized, incubated at 37 or 
70°C, and subjected to rate zonal sucrose density gradient centrifugation to 
determine the oligomeric state of E (Fig. 7). E trimers of the single mutants 
H248N, H287A and H438N were as stable as WT trimers (Fig. 7 and not 
depicted). In contrast, not only was trimer formation with H323A and H248N-
287A less efficient (Fig. 5, C and D) but also these trimers were sensitive to 
incubation at 70°C, as revealed by a strong reduction of the E trimer peak and 
an accumulation of presumably denatured and aggregated material in the pellet 
(Fig. 7). As expected, similar results were obtained when trimer formation was 
allowed to proceed in the presence of liposomes (unpublished data). 
Collectively, these results allow two important conclusions: (1) the lack of fusion 
activity of mutant H248N-H287A is likely to be caused by an impairment of trimer 
formation combined with a reduction in trimer stability, and (2) H323 apparently 
has a double role in the fusion process and not only functions as a pH sensor for 
initiating fusion but also contributes to the stability of the post-fusion trimer. 
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Figure 5. Analysis of acidic pH-induced trimer formation with WT and mutant RSPs by rate 
zonal gradient centrifugation. (A-D) RSPs were incubated for 10 min at pH 5.4 (solid line), or 
pH 8.0 (dotted line), back-neutralized, solubilized with 1% Triton X-100, and analyzed by 
sedimentation in 7-20% sucrose gradients containing 0.1% Triton X-100. The gradients were 
fractionated, and the amount of E protein in each fraction was determined by a quantitative four-
layer ELISA. The sedimentation direction is from left to right. Peak of the E dimer, fraction 8; 
peak of the E trimer, fraction 10.   
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Figure 6. pH threshold of E trimer formation of RSP WT and mutants. Extent and pH 
dependence of acidic pH-induced E trimer formation with WT and mutant RSPs as determined 
by rate zonal sucrose density centrifugation. Results are expressed as a percentage of E found 
in the trimer peak fractions relative to the total amount of E in the gradient. 
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Figure 7. Analysis of the stability of acidic pH-induced E trimers of WT and selected 
mutant RSPs. Acidic pH-induced trimers of WT (red) and mutant RSPs (green, H248N; orange, 
H323A; blue, H248N-H287A) were exposed to 70°C and subjected to rate zonal sucrose density 
gradient centrifugation. The sedimentation direction is from left to right. The pellet (P) was 
resuspended in 0.6 ml corresponding to the volume of a single fraction. 
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1.4. Discussion 
 
 
 
Although histidines have been speculated to play an important role as acidic pH 
sensors in class II viral fusion proteins (Bressanelli et al., 2004; Kampmann et 
al., 2006; Kanai et al., 2006; Nybakken et al., 2006; Roussel et al., 2006; Mueller 
et al., 2008), experimental evidence for such a role is still lacking. The mutational 
analysis presented in this work suggests that one of the five conserved 
hisitidines in the TBEV E protein (His323) plays a dominant role in the initiation 
of the multistep fusion process. This amino acid residue forms part of an intricate 
intramolecular network of interactions between DI and III of the E monomer in its 
pre-fusion conformation, consisting of hydrogen bonds, van der Waals contacts 
and a salt bridge between Arg9 in DI and Glu373 in DIII (Fig. 8 A; Bressanelli et 
al., 2004). Both of these amino acids as well as several additional residues of 
this contact area are absolutely conserved among flaviviruses (Bressanelli et al., 
2004). The integrity of this domain interface is essential for the dimeric 
conformation of E in mature virions because only in this specific arrangement do 
the two domains together provide a protective pocket for the FP loop at the tip of 
DII of the second subunit (Fig. 1 B and Fig. 8 A). Through these and other DII 
interactions, the monomeric subunits are fixed in an antiparallel orientation in the 
E dimer. The release of these constraints is necessary for exposing the FP and 
allowing an outward projection of the E monomers as a prerequisite for target 
membrane interactions (Mukhopadhyay et al., 2005; Stiasny and Heinz, 2006; 
Harrison, 2008). Inspection of the post-fusion structure suggests that His323 
may form an intradomain salt bridge with Glu373. Because in the pre-fusion 
conformation Glu373 is part of the central salt bridge together with Arg9, the 
protonation of His323 is likely to contribute to the dissolution of this salt bridge 
and to the concomitant destabilization of the DI-III interface. The fact that the 
basic architecture of these networks is conserved in the pre- and post-fusion 
forms of E from TBEV and the distantly related dengue 2 virus (His323 and 
His317 and Glu373 and Glu368, respectively) would argue for a similar 
mechanism of fusion initiation in all flaviviruses (Rey et al., 1995; Bressanelli et 
al., 2004; Modis et al., 2003, 2004). 
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The DI-III interface contains another absolutely conserved histidine at position 
146 (Fig. 8 A), which we were not able to investigate directly because its 
replacement by any of the other 19 amino acids abolished the formation of 
native RSPs by the quality criteria applied. 
Although the mutation H323A dramatically reduced the acidic pH-induced 
exposure of the FP, there was some residual activity that occurred at the same 
pH threshold of 6.6. Because all of the other His mutations as well as their 
combinations did not impair FP exposure, the residual activity is probably related 
to the protonation of His146 and suggests a possible accessory role of this 
residue in the destabilization of the DI-III interface. Surprisingly, and in contrast 
to what has been observed for the influenza virus class I fusion protein 
hemagglutinin (Thoennes et al., 2008), none of the histidine mutations in this 
work affected the pH threshold of fusion-related processes. Flavivirus variants 
that exhibited a pH shift for membrane fusion were described to contain 
mutations in the DI-II hinge region (Rey et al., 1995; Harrison, 2008), but the 
mechanism causing this behaviour remains to be elucidated. It has been 
suggested, however, that these mutations influence the stability of E (Modis et 
al., 2003) and thus may modulate the pH required to induce those 
conformational changes that drive fusion. Such “stability effects”, however, 
appear to be distinct from the actual pH-sensoring machinery which apparently 
involves His323 and probably His146. 
The conversion of the E dimer to the post-fusion trimer not only requires the 
relocation of DIII but also a change in the orientation of DII relative to DI 
(Bressanelli et al., 2004; Modis et al., 2004). This is made possible by the 
structural flexibility of the junction between the two domains (Modis et al., 2003), 
which is also necessary for conformational transitions during other phases of the 
viral life cycle, such as virus assembly and maturation (Zhang et al., 2004; Li et 
al., 2008). In the context of fusion, this hinge motion may occur spontaneously 
upon release from dimer constraints, caused by the dissolution of the DI-III 
interface, but could also require an independent pH-sensoring step (Kanai et al., 
2006). With respect to the conserved histidine at the DI-II junction (His287), we 
did not, however, find evidence for such a pH sensor function, because its 
replacement did not have any measureable effect, neither on early nor late 
stages of fusion. 
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It is a further finding of our work that His323 apparently has a dual role in the 
fusion process and contributes both to the initial pH trigger and to the stability of 
the post-fusion trimer. The lower stability of this mutant trimer could be due to 
the lack of the salt bridge between His323 and Glu373 in the post-fusion 
structure of DIII (Fig. 8 B) and a concomitant weakening of DIII-mediated trimer 
contacts and/or the proper positioning of the stem for zippering along the 
grooves provided by DII. None of the other conserved histidines (except His146, 
which was irreplaceable and therefore not amenable to analysis) seems to have 
a similar impact on E trimerization as His323, because their single replacements 
neither affected trimer formation nor trimer stability to a measurable extent (Fig. 
7). An additive effect, however, was observed in the double mutant H248N-
H287A which was fusion negative and as impaired in trimer formation and trimer 
stability as was the mutant H323A. His287 forms part of the trimer interfaces 
(Fig. 1 C) and His248 is located at a position at the groove, close to the FP (Fig. 
1 C), that is likely to accommodate the stem during the 'zipping up' process (Fig. 
1 D). Theoretically, the replacement of each of these residues alone could 
interfere with late stages of the fusion process, leading to the opening of the 
fusion pore. More specific interpretations of these results, however, will depend 
on the elucidation of the atomic structure of the stem in the post-fusion structure 
of E and assays that distinguish between lipid and contents mixing. 
Although three of the conserved histidines in TBEV E (His248, His287, and 
His438) were ruled out as pH sensors for initiating fusion, they could be involved 
in other pH-dependent mechanisms, such as the conversion of immature 
(containing prM-E) into mature particles (Yu et al., 2008). The structure of the 
prM-E heterodimer of dengue 2 virus has recently been determined by X-ray 
crystallography and it is of special interest that His244 (corresponding to His248 
in TBEV-E) is situated opposite a conserved Asp63 in prM (Li et al., 2008). It has 
therefore been speculated that the loss of protonation of His244 could be 
required for the release of the pr-peptide at neutral pH (Li et al., 2008; Yu et al., 
2008). In our TBEV system, the replacement of the homologous His248, 
however, had no apparent effect on virus maturation and further experiments will 
be necessary to clarify this issue. 
Despite the structural similarity of the class II fusion proteins of alphaviruses (E1) 
and flaviviruses (E) (Kielian, 2006), it is likely that the pH-sensoring machinery 
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for initiating fusion is significantly different in the two virus systems. Indeed, there 
is only one conserved histidine at a strictly homologous position in E and E1. 
This residue (His248 in TBEV and His230 in Semliki Forest Virus, respectively), 
however, has been ruled out as a pH sensor for both viruses and was shown to 
affect only a late stage of fusion (Chanel-Vos and Kielian, 2004, 2006; this 
study). The major difference lies in the structural details of FP protection in the 
pre-fusion conformations of E and E1. In flaviviruses, the FP in E is buried 
through homodimeric interactions, whereas in alphaviruses, the FP in E1 is 
protected by a heterodimeric interaction with a second, overlying protein (E2) 
(Kielian, 2006). Alphavirus fusion could therefore be triggered by the protonation 
of as yet unidentified residues in both E1 and E2. 
In conclusion, our study provides experimental information on the pH trigger of 
flavivirus membrane fusion and the critical role of the DI-III interface in this 
process. Although several of the absolutely conserved histidines in the viral 
fusion protein were shown to be completely dispensable for fusion initiation, our 
study does not rule out possible roles of these residues in other pH-dependent 
processes of the viral life cycle. These new insights can also contribute to the 
design of antiviral approaches that target the structural transitions of flaviviruses 
during entry and morphogenesis. 
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Figure 8. Intramolecular interactions of DIII in the pre- and post-fusion structures of sE. (A) 
Ribbon diagrams of the TBEV sE dimer and the details of the DI-III interface in the pre-fusion 
conformation with the central salt bridge between Arg9 and Glu373. (B) Ribbon diagrams of the 
TBEV sE trimer and the details of DIII in its post-fusion conformation revealing the possible salt 
bridge between His323 and Glu373. 
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Table S1. Summary of histidine mutations that abolished the secretion of RSPs 
 
Mutant                      Location of mutation 
  H146A domain I 
  H146G domain I 
  H146V domain I 
  H146L domain I 
  H146I domain I 
 H146M  domain I 
  H146F domain I 
  H146Y domain I 
 H146W domain I 
  H146S domain I 
  H146P domain I 
  H146T domain I 
 H146C domain I 
 H146N domain I 
 H146Q domain I 
 H146K domain I 
 H146R domain I 
 H146D domain I 
 H146E domain I 
 H248A domain II 
 H248I domain II 
 H287G domain I 
 H287Q domain I 
 H287K domain I 
 H323I domain III 
 H323N domain III 
 H323K domain III 
 H323D domain III 
 H438A  stem 
 H438I  stem 
 H438K  stem                    
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1.5. Materials and Methods 
 
 
 
 
1.5.1. Mutagenesis of RSPs 
Using the site-directed mutagenesis kit “Gene Tailor TM” of Invitrogen, mutations 
were introduced into the recombinant plasmid SV-PE WT (Allison et al., 1994), 
which contained the TBEV prM and E genes under the control of an SV40 early 
promoter, at the codon positions 146, 248, 287, 323, and 438 of the E gene. The 
WT and mutant plasmids were sequenced throughout the prM and E regions to 
confirm that only the desired mutations were present. 
 
 
1.5.2. Production of RSPs 
For the production of RSPs, COS-1 cells were transfected with recombinant 
plasmids by electroporation as described previously (Schalich et al., 1996). 
RSPs were harvested 48 h after transfection from cell culture supernatants, 
pelleted by ultracentrifugation and purified by sucrose gradient centrifugation ( 
Schalich et al., 1996; Allison et al., 2001). For membrane fusion (lipid mixing) 
assays, the RSPs were metabolically labeled with 1-pyrenehexadecanoic acid 
(Molecular Probes) as described previously (Corver et al., 2000; Allison et al., 
2001). 
 
 
1.5.3. Quality controls of RSPs 
The amount of RSPs secreted from transfected cells was quantified by a four-
layer ELISA after solubilization with 0.4% sodium dodecyl sulfate at 65°C for 30 
min (Heinz et al., 1994). The conformation of E was probed in comparison to that 
of the WT by epitope mapping with 22 E protein-specific mabs (Allison et al., 
1995, 2001; Heinz et al., 1994; Stiasny et al., 2005) and their maturation state 
(presence of prM) was analyzed by Western blotting (Allison et al., 2003). 
 
 
 
 66
1.5.4. pH treatment of RSPs 
Acidic pH incubations were carried out at 37°C and the different acidic pHs were 
adjusted by the addition of morpholinoethansulfonic acid (MES) ranging from 80 
to 300 mM to the samples in TAN buffer, pH 8.0 (50 mM triethanolamine, 100 
mM NaCl). Controls were incubated in TAN buffer, pH 8.0. 
 
 
1.5.5. Lipid mixing fusion assay 
Pyrene-labeled RSPs were mixed with large unilamellar liposomes (0.3-mM total 
lipid) consisting of phosphatidylcholine, phosphatidylethanolamine, and 
cholesterol (molar ratio, 1:1:2) in a continuously stirred fluorimeter cuvette at 
37°C (Allison et al., 2001; Stiasny et al., 2003). Fluorescence was monitored 
continuously using a fluorescence spectrophotometer (Perkin-Elmer). Lipid 
mixing was initiated by the addition of MES to yield a final pH of 5.4. The extent 
of fusion was calculated by using the initial excimer-fluorescence as 0% fusion 
and the fluorescence after solubilization of the RSP-liposome mixture by the 
detergent octa(ethylene glycol)-n-dodecyl monoether (Sigma-Aldrich) as 100% 
fusion. 
 
 
1.5.6. Coflotation assay 
Purified RSPs were mixed with liposomes with the same composition as those 
used in the fusion assays at a ratio of 1µg E protein to 200 nMol of lipids. The 
mixture was acidified by the addition of MES to yield a pH of 5.4 and incubated 
for 15 minutes at 37°C. After back-neutralization by the addition of 150 mM 
triethanolamine to yield a final pH of 7.8, sucrose was added to the RSP-
liposome mixture to a final concentration of 20% (wt/wt). This 0.6-ml sample was 
layered onto a 1-ml cushion of 50% sucrose in TAN buffer, pH 8.0, and overlaid 
with 1.4 ml of 15 % sucrose and 1 ml of 5 % sucrose (Allison et al., 2001; 
Stiasny et al., 2002). The step gradients were centrifuged for 2 h at 4°C (rotor 
SW 55; Beckman Coulter) at 50,000 rpm, and 0.2-ml fractions were collected by 
upward displacement using a Piston Gradient Fractionator (BioComp 
Instruments Inc.). E protein was quantified by four-layer ELISA after 
solubilization with 0.4% sodium dodecyl sulfate at 65°C for 30 min (Heinz et al., 
1994). 
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1.5.7. Fusion peptide exposure assay 
Native RSPs (at a concentration of 0.5 µg/ml of E protein) in phosphate-buffered 
saline, pH 7.4, containing 2% lamb serum were captured by polyclonal anti-
TBEV immunoglobulin G for 1 h at 37°C as described previously (Stiasny et al., 
2007). The exposure of the FP was measured by the addition of biotinylated 
mAb A1 (FP-specific mab) in MES buffer (50 mM MES, 100 mM NaCl), titrated 
to the appropriate pH by titration with 1N NaOH. After incubation for 1 h at 37°C, 
the bound antibody A1 was detected by using streptavidin-peroxidase (Sigma-
Aldrich). 
 
 
1.5.8. E trimer formation and stability 
The acidic pH-induced E dimer-to-trimer transition was measured by 
sedimentation analysis as described previously (Allison et al., 1995, 2001). 3 µg 
RSPs in TAN buffer, pH 8.0, were adjusted to different acidic pHs by the addition 
of MES (see pH treatment of RSPs) and incubated at 37°C for 10 min. Samples 
were back-neutralized with 150 mM triethanolamine, solubilized for 1 h at room 
temperature with 1% Triton-X 100, and applied to 7-20% (wt/wt) continuous 
sucrose gradients containing 0.1% Triton-X 100. Centrifugation was performed 
for 20 h at 38.000 rpm at 15°C (rotor SW 40; Beckmann Coulter). 0.6-ml 
fractions were collected by upward displacement using a Piston Gradient 
Fractionator, and the amount of E in each fraction was determined by an E-
specific four-layer ELISA after treatment with 0.4% sodium dodecyl sulfate at 
65°C for 30 minutes (Heinz et al., 1994). To investigate the thermostability of the 
post-fusion E protein, acidic pH-pretreated and solubilized RSPs were incubated 
at 37 and 70°C before sedimentation analysis (Stiasny et al., 2005). 
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Viruses that infect cells by uptake through endosomes have generally evolved to 
“sense” the local pH as part of the mechanism by which they penetrate into the 
cytosol. Even for the very well studied fusion proteins of enveloped viruses, 
identification of the specific pH sensor has been a challenge, one that has now 
been met successfully, for flaviviruses, by Fritz et al. (Fritz, R., K. Stiasny, and 
F.X. Heinz. 2008. J. Cell Biol. 183: 353–361) in this issue. Thorough mutational 
analysis of conserved histidine residues in the envelope protein of tick-borne 
encephalitis virus led Fritz et al. (2008) to identify a histidine at a key domain 
interface as the critical pH sensor; its protonation triggers the large-scale 
conformational rearrangement that induces fusion of viral and endosomal 
membranes. 
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The acidic pH of endosomes is one of their simplest distinguishing 
characteristics. Most viruses that pass through these compartments en route to 
productive infection have evolved to “sense” the local proton concentration as 
part of their mechanism for crossing into the cytosol. For enveloped viruses, 
fusion of their lipid bilayer with the membrane of an endosome is generally the 
pH-dependent molecular step, catalyzed by a “fusion protein” on the viral surface 
(Harrison, 2008; White et al., 2008). Although these proteins have been studied 
in great detail for over 30 yr, it has not been easy in any of the well characterized 
examples to pin down the molecular identity of the pH sensor. Histidine residues 
are plausible candidates, as they titrate in the relevant range, but suitably poised 
carboxylate pairs can have a similar pK. The long history of working out the 
origins of the haemoglobin Bohr effect show how tricky such a search can be 
(e.g., see Riggs, 1988). Moreover, charge interactions, even those with 
conserved physiological functions, can move around on a protein relatively 
easily in the course of evolution. For example, a redundant charge pair can 
appear by mutation, with a similar pK as that of an existing one, allowing the 
initial charges to disappear in some subsequent evolutionary step, without 
drastic change in titration properties. Exquisite stereochemistry is often not 
required.  
Fritz et al. (2008) (see p. 353 in this issue) have taken on the challenge of 
determining the pH sensor for flavivirus fusion by meticulous and exhaustive 
mutational analysis of conserved histidine residues in the fusion protein of tick-
borne encephalitis virus (TBEV). Their work builds upon elegant analyses of 
TBEV fusion by Heinz and co-workers over many years, including their essential 
contributions to structure determinations of the protein, both at neutral pH and 
after acidification (Rey et al., 1995; Bressanelli et al., 2004). Flaviviruses are 
particularly compact structures, only ~ 500 Å in diameter, tiled on their surface 
by 180 envelope protein (E) subunits in an icosahedral array (Zhang et al., 
2003), as illustrated in Fig. 1 a . Within this outer layer is the viral membrane, a 
roughly spherical bilayer ~ 410 Å in outer diameter. The viral positive-strand 
RNA genome encodes three structural proteins — an internal, RNA packaging 
“core” protein (C) and two membrane-anchored proteins, prM and E ( 
Lindenbach et al., 2007 ). A C protein – RNA complex buds into the endoplasmic 
reticulum, acquiring a membrane with 180 prM-E heterodimers in the process. 
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The prM protein is a specific chaperone for E (Fig. 1 b). In the trans-Golgi 
network (TGN), furin cleavage of prM to a membrane-anchored residual 
fragment (called M) allows E to settle into the regular array illustrated in Fig. 1 a 
and also allows it to undergo (when subsequently acidified) the low pH – 
induced, dimer-to-trimer reorganization shown in Fig. 2. Thus, when the mature 
virus particle secreted by one cell arrives in the acidic environment of an early 
endosome in a target cell, the large-scale molecular rearrangement of E 
facilitates fusion, first by exposing a hydrophobic “fusion loop”, which inserts into 
the endosomal membrane, and then by drawing together the viral and target 
membranes as the conformational change proceeds. 
In the 1990’s, Heinz and co-workers (Allison et al., 1995; Schalich et al.,1996) 
showed that recombinant expression of TBEV prM and E in mammalian cells 
leads to secretion of recombinant subviral particles (RSPs), smaller than virions 
but still with an intact lipid bilayer. Later analysis showed that they contain just 
60 copies of E (and, after passage through the TGN, the same number of copies 
of M), icosahedrally arrayed, and that the bilayer is only ~ 210 Å in outer 
diameter (Ferlenghi et al., 2001). These particles nonetheless fuse with 
liposomes or other target membranes, at lowered pH, in a reaction that has 
precisely the same characteristics as virion fusion (Corver et al.,2000). For 
example, as described by Fritz et al. (2008), the reactivity of E with a panel of 22 
monoclonal antibodies, with quite differently positioned epitopes, changes in just 
the same way during viral fusion and RSP fusion. The pH dependence and the 
kinetics of the process are likewise the same. As RSPs can be produced by 
transient transfection, mutagenesis is far more straightforward than it would be 
with virions. Fritz et al. 
(2008) could therefore pursue their hypothesis that histidines in E conserved 
among all flaviviruses are the likely pH sensors by an essentially complete 
analysis of the five such residues in TBEV. They monitored fusion by labeling 
the RSP membranes with 1-pyrenehexadecanoic acid, which has substantially 
altered fluorescence properties when diluted into the target membrane after 
merger of the bilayers. 
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Figure 1. Flavivirus structure. (a) Diagram of the packing of 180 E subunits in the surface of a 
virion. The proteins are clustered as dimers. Each is represented by a symbol, colored to 
correspond to the domain representation in b. (b) The ectodomain of the E dimer, viewed as if 
looking toward the surface of the virion. Domains I, II, and III are labeled and colored in red, 
yellow, and blue, respectively. An arrow points to the fusion loop on one subunit. The locations of 
two histidines at the domain I – domain III interface are shown by orange triangles. His 146 is on 
domain I; His 323, close to the fusion peptide of the partner subunit, is on domain III. Black 
triangles mark a potential receptor-binding loop. 
 
 
 
 
 
 
 
 
 
Figure 2. Sequence of events during low pH-triggered, fusion-inducing conformational 
rearrangements of flavivirus E proteins. (a) E ectodomain dimer, viewed as in Fig. 1 b . (b) 
Side view of the E dimer, illustrating how it is anchored in the viral membrane. A segment known 
as the stem connects the C terminus of domain III to the transmembrane anchor (a helical 
hairpin that traverses the bilayer once in each direction). (c) Low pH induces dissociation of the 
dimer interface and rotation outward of domains I and II, exposing the fusion loop (black arrows), 
which interacts with the endosomal target membrane. (d) The extended intermediate trimerizes 
and starts to collapse (curved arrows), so that domain III rotates back to dock against domains I 
and II and the stem zips up alongside the trimer-clustered domain II. (e) When the transition is 
complete, the two membranes have been brought together and induced to fuse. Several trimers 
probably participate cooperatively in this process, but only one is shown here. (This figure has 
been modified from Harrison, 2008.) 
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Two of the five conserved histidines (H146 and H323) are at a particularly 
“interesting” interface between domains I and III of the E protein (see Fig. 1 b), 
and several previous papers (Bressanelli et al., 2004; Kampmann et al., 2006) 
had called attention to them. This interface rearranges completely when the 
protein undergoes its fusion-inducing change from dimer to trimer (Fig. 2), and 
protonation might indeed be expected to destabilize the dimer conformation. 
Two of the other conserved histidines (H248 and H287) are on the protein 
surface; the fifth (H438) is in the so-called stem that links domain III to the 
transmembrane anchor. Fritz et al. (2008) show that any of these last three can 
be mutated individually, without effect on the fusion properties of the 
corresponding RSPs, whereas mutation of H323 to alanine eliminates fusion, 
even at pH 5.0. Mutation of H146 to any of the other 19 naturally occurring 
amino acid residues prevents stable expression of E and hence prevents any 
formation of RSPs. H323 is not only buried at a key domain interface, it is also 
part of the pocket that protects the fusion loop of the dimer partner. Fritz et al. 
(2008) convincingly conclude that H323 is the critical pH sensor, with a possible 
additional contribution from H146. 
Fritz et al. (2008) also examine a series of double and triple mutations. One of 
the double mutants, H248A-H287A, gives rise to stable RSPs but prevents 
fusion. In earlier work, Stiasny et al. (2007) found, by using a monoclonal 
antibody directed against the fusion loop, that its epitope, buried in the prefusion 
E dimer, is transiently exposed during the fusion process and becomes again 
protected in the postfusion trimer. As might be expected from its location, the 
H323A mutation prevents even the process (presumably dissociation of the 
dimer interface) that makes this epitope transiently accessible after acidification. 
The same is not the case for the H248A-H287A double mutant, however; 
lowered pH allows binding of the fusion loop monoclonal, just as to wild-type 
RSPs. The likely interpretation is that the double mutation impairs a later step in 
the fusion reaction. A good candidate would be the transition from the extended, 
intermediate structure (Fig. 2 c) to the folded back trimer (Fig. 2 e). The trapped 
intermediate is probably still monomeric, as suggested by sedimentation 
analysis of solubilised E protein from the various RSPs. Both H248 and H287 
are in locations compatible with a contribution to trimer stability. The double 
 80
mutant also binds liposomes at lowered pH, confirming exposure of its 
hydrophobic fusion loops. 
Animating molecular structures and probing the processes in which they 
participate is still an arduous business. Directed mutagenesis, however well 
informed by structural information, is often a relatively blunt instrument. By 
building on nearly two decades of careful work on TBEV and its surface proteins, 
Fritz et al. (2008) have done more than simply identify the pH sensor that 
triggers E protein rearrangement, challenging as even that task has been. 
Together with the work of Liao and Kielian (2005) on the related alphavirus 
fusion proteins (and on dengue, another flavivirus), the experiments described in 
their paper fill in steps of the mechanism, illustrated in Fig. 2, for which we have 
had until now mainly the logical deductions from structures of the two end states. 
Methods to track the fusion of individual virus particles, by extension of the type 
of fluorescence assay used by Fritz et al. (2008), are likely soon to add further 
details and a proper time dimension. One should also recall that motivation to 
understand the details of this process goes beyond its considerable inherent cell 
biological interest. Blockade of fusion is among the mechanisms by which 
neutralizing antibodies prevent infection, and inhibiting viral fusion is a validated 
antiviral strategy, with at least one fusion inhibitor (the HIV entry inhibitor, 
enfuvirtide) now a licensed drug. 
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IV. PART II 
 
 
 
Role of the second transmembrane domain of E in 
flavivirus fusion  
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1.1. Abstract 
 
 
 
The flavivirus envelope protein E is the only known viral fusion glycoprotein with 
a membrane anchor consisting of two transmembrane helices. To investigate the 
role of the second transmembrane helix (TM2) in flavivirus membrane fusion, 
this region of E was deleted in recombinant subviral particles (RSPs) of tick-
borne encephalitis virus (TBEV). In vitro lipid mixing experiments revealed that 
∆TM2 RSPs were fusion deficient. Experimental dissection of the fusion process 
showed that TM2 was not involved in the establishment of initial interactions with 
target membranes, but essential for the formation of a stable post-fusion 
structure of E. 
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1.2. Introduction 
 
 
 
Viral fusion proteins as well as SNARE (soluble N-ethylmaleimide sensitive 
factor attachement protein receptors) proteins – a family of membrane-anchored 
proteins essential for intracellular membrane fusion – possess highly conserved 
transmembrane domains (TMDs). In many cases, these domains have been 
shown to be required for full membrane fusion (reviewed in Schroth-Diez et al., 
2000; Langosch, Hofmann and Ungermann, 2007). Only in some reports the 
TMDs of viral fusion proteins were described to be functionally irrelevant (Wilk et 
al., 1996; Odell et al., 1997). To assess their role for fusion, the TMDs have 
been mutated, truncated or replaced with other anchors.  
The replacement of the TM domain of the influenza hemagglutinin with a 
glycosylphosphatidylinositol (GPI) anchor allowed lipid mixing and fusion pore 
formation, but blocked pore enlargement and thus full fusion. A block before the 
opening of the fusion pore was also observed by the insertion of a certain point 
mutation into the transmembrane domain of HA or by the truncation of this 
region (Kemble, Danieli and White, 1994; Nuessler, Clague and Herrrmann, 
1997; Markosyan, Cohen and Melikyan, 2000; Melikyan et al., 1997, 1999, 2000; 
Armstrong, Kushnir and White, 2000) (Table 1). In TMDs of other viral fusion and 
SNARE proteins the introduction of specific alterations had similar effects 
(McGinnes, Sergel and Morrison, 1993; Salzwedel et al., 1993; Cleverly and 
Lenard, 1998; Taylor and Sanders, 1999; Browne et al., 2003; Liao and Kielian, 
2005; Xu et al., 2005; Miyauchi et al., 2006; Bissonnette et al., 2008; Li and 
Blissard, 2008) (Table 1). 
These experimental analyses revealed that the initial stage of fusion i.e. the 
bridging of the two lipid bilayers by fusion proteins was not facilitated by the 
specific TMDs investigated. Many TMDs, however, were found to be required for 
the completion of fusion i.e. the transition from the hemifusion state to the 
opening of the fusion pore. The hemifusion state is a generally accepted 
intermediate, resulting in an hourglass-shaped stalk structure. Expansion of the 
stalk is thought to result in the formation of the hemifusion diaphragm. Within the 
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diaphragm the fusion pores are formed and their expansion leads to the fully 
fused state of the membrane (Fig. 6).  
The concept of the existence of the hemifusion stalk was essentially supported 
by the investigations of viral TMDs (reviewed in Chenomordik and Kozlov, 2003, 
2008; Langosch, Hofmann and Ungermann, 2007).     
 
 
Table 1. Effect of TMD alteration on viral fusion protein function  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fusion protein Alteration Effect
Influenza HA
Influenza HA
Influenza HA
Influenza HA
VSV G
VSV G
VSV G
HIV gp120
HIV gp120
HIV gp120
HIV gp120
Measles virus F
Newcastle disease virus HN
Morony murine leukemia virus E
Reovirus p10
HSV-1 gD
HSV-1 gH
SFV E1
Replacement by GPI anchor
Replacement by unrelated TMDs
G520L mutation
Shortening of TMD 
Adapted and extended from Langosch, Hofmann and Ungermann, 2007
Replacement by GPI anchor
Mutation of GxxxG motif
Replacement by unrelated TMDs
Replacement by GPI anchor
Various mutations and truncations
Replacement by VSV G TMD
Mutation of GGxxG motif
Mutation of cysteine residues
Mutation of leucine zipper repeat
Mutation of P617
Mutation of glycine motif
Replacement by GPI anchor
Various mutations
Mutation of glycine residues
Abolished fusion, 
retained hemifusion
Fusion retained
Abolished fusion, 
reduced hemifusion
Abolished fusion, 
retained hemifusion
Abolished fusion
Abolished fusion, 
retained hemifusion
Fusion retained
Reduced syncytia formation
Reduced syncytia formation
Reduced lipid mixing
Reduced cell-cell fusion
Reduced cell-cell fusion
Reduced fusion 
promoting activity
Reduced fusion
Reduced syncytia formation
Reduced cell-cell fusion
Reduced cell-cell fusion
Reduced cell-cell fusion
Paramyxovirus F L486A, I488A mutations Abolished syncytia formationReduced fusion
AcMNPV gp64 Replacement by various TMDs Abolished fusion, retained hemifusion
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For several flaviviruses atomic details of both, the pre-fusion and the low pH-
induced post-fusion forms of the E ectodomain are known from x-ray 
crystallography of sE (Rey et al., 1995; Modis et al., 2003, 2004; Bressanelli et 
al., 2004; Zhang et al., 2004; Modis et al., 2005; Nybakken et al., 2006). Cryo-
electron microscopy images allowed the investigation of the C-terminal part of 
native DenV 2 E, that is absent in sE, i.e. the “stem-anchor” region (Zhang et al., 
2003). The 56-residue stem region contains two mostly amphipathic alpha 
helices – half buried in the outer lipid leaflet – followed by two transmembrane 
alpha helices (TM1 and TM2; that travers the lipid bilayer from the external to the 
internal and back to the external lipid leaflet) forming the anchor (Fig. 1). The two 
TM helices are oriented antiparallel to each other and are linked by four to six 
mostly polar amino acids which are presumably buried within the inner lipid 
leaflet (Zhang et al., 2003). Since the E protein is not exposed on the 
cytoplasmic side of the viral membrane, it does not possess a cytoplasmic tail 
found in many other viral fusion proteins. The structure and organization of the 
transmembrane domains of flavivirus E is unique – all other viral fusion proteins 
and SNAREs posses single TMDs only – and the role of the double membrane 
anchor in fusion has so far not been investigated.  
In this study, subviral particles of TBEV were used as a model, and the second 
TMD of E was deleted to investigate whether this element plays a role in 
flavivirus membrane fusion. TM2 was found to be important for the overall fusion 
process, but not required during the early phases of fusion. E trimerization was 
not dependent on the presence of TM2, however, in its absence the trimers 
formed were significantly less thermostable. Overall the fusion process seems to 
be dependent on the formation of a stable E post-fusion trimer that requires the 
presence of TM2. 
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Figure 1. Schematics of the membrane-anchored TBEV E protein (A, B) and 
representation of the C-terminal sequence elements of E proteins (C). Membrane-
anchored E in its pre-fusion (A) and post-fusion (B) conformations (side view). The stem and 
the membrane anchor both consist of two helices: H1, stem helix 1; H2, stem helix 2; TM1, 
transmembrane helix 1; TM2, transmembrane helix 2. Color code: E protein domain I (DI), 
red; DII, yellow; DIII, blue; stem helices, purple; transmembrane anchors, green; membrane, 
grey. (C): In ∆TM2 RSPs the second transmembrane helix of E was deleted. Numbers 
indicate amino acid positions. 
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1.3. Results 
 
 
 
1.3.1. Generation of RSPs lacking TM2 
 
To investigate the role of the second TMD of the flavivirus envelope protein E in 
membrane fusion, recombinant subviral particles (RSPs) of TBE virus containing 
C-terminally truncated E proteins  with only the first TM helix were used (∆TM2) 
(Fig. 1 C). As shown previously (Allison et al., 1999), TM1 is sufficient for 
incorporation of E into RSPs. 
∆TM2- as well as WT-particles were generated as described (Allison et al., 1995, 
1999) (Materials and Methods) and were subjected to particle quality controls as 
described (Fritz, Stiasny and Heinz, 2008) (Materials and Methods), including 
epitope mappings with selected E protein specific monoclonal antibodies (mabs) 
and analysis of the particle’s prM content, to ensure proper protein folding and 
processing. ∆TM2 RSPs displayed WT-like properties in all assays and could 
therefore be used to study the role of TM2 in TBE virus membrane fusion. 
 
 
1.3.2. Loss of fusion activity by deletion of TM2 
 
To assess the effect of the deletion of TM2 on the overall fusion process, an in 
vitro lipid mixing assay was performed as described previously (Corver et al., 
2000). For this purpose, RSPs with membranes that were metabolically labelled 
with 1-pyrenehexadecanoic acid were mixed with liposomes. The mixture was 
acidified and membrane fusion was measured by continuous detection of the 
decrease of pyrene excimer fluorescence due to the dilution of the probe into 
unlabelled liposomal membranes. 
As depicted in Figure 2, WT RSPs displayed fast and efficient fusion kinetics. In 
contrast, fusion of ∆TM2 RSPs was virtually abolished (Fig. 2 A, B). 
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Figure 2. Fusion activity of pyrene-labelled WT- and ∆TM2-RSPs. (A): Fusion kinetics of 
WT (black line) and ∆TM2 (grey line) RSPs at pH 5.4. (B): Extent of fusion of ∆TM2 RSPs at 
pH 5.4 after 60 s. Three independent experiments were carried out with similar results. The 
error bars represent the standard error of the mean. 
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1.3.3. TM2 is not required for the early stages of fusion 
 
 
The lipid mixing experiments revealed an important role for the second helix of 
the flavivirus membrane anchor in the overall fusion process. The next goal was 
to determine at which step of fusion TM2 is essential.  
To investigate the first event of the fusion cascade, dissociation of E dimers and 
fusion peptide (FP) exposure, the FP specific mab A1 was used. Upon low pH-
induced dimer dissociation, A1 gains increased access to its epitope as decribed 
previously (Fritz, Stiasny and Heinz, 2008) and in Materials and Methods. 
As shown in Figure 3, no difference was found in low pH-induced FP exposure 
between WT- and ∆TM2-RSPs. In both cases, the increase of A1 binding 
occurred at the same pH threshold and to the same extent. 
FP exposure allows stable interactions of the fusion protein with target 
membranes. To assess whether ∆TM2 E can bind to membranes, coflotation 
assays with liposomes were carried out as described previously (Stiasny et al., 
2002; Fritz, Stiasny and Heinz, 2008). WT- and ∆TM2-RSPs were mixed with 
liposomes, acidified, and applied to sucrose step gradients (Methods). 
Coflotation of E with liposomes to the top of the gradients indicates either binding 
to or fusion with liposomes. In accordance with FP exposure, ∆TM2 RSPs were 
shown to bind to liposomal target membranes as efficiently as WT particles (Fig. 
4 A, B). 
To confirm that the observed coflotation of ∆TM2 RSPs was only due to 
attachement to – but not fusion with – liposomes, coflotation experiments with 
pyrene-labelled RSPs were performed and the pyrene fluorescence spectra were 
recorded as described (Fritz, Stiasny and Heinz, 2008). Figure 4 C shows that 
membrane fusion of WT particles with liposomes – occurring in coflotation 
experiments – led to a strong reduction of the pyrene excimer peak, whereas 
there was no such reduction for ∆TM2 RSPs. This confirms that they were only 
attached but not fused to the liposomes. 
Taken together, the experimental data indicated that the deletion of TM2 of the 
flavivirus E protein membrane anchor had no effect on the initial stages of fusion. 
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Figure 3. Low pH-induced dimer dissociation and FP exposure measured by binding of 
mab A1. Results are represented as percent of A1 reactivity with WT E at p 5.4. Data are 
averages of four independent experiments performed in duplicates. The error bars represent 
the standard error of the mean. WT: solid boxes; ∆TM2: open diamonds. 
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Figure 4. Low pH-induced coflotation of WT- and ∆TM2-RSPs with liposomes.  
A: Representative example of the results obtained from coflotation experiments at pH 5.4.  
WT: solid boxes; ∆TM2: open diamonds. The bracket indicates the fractions containing 
liposomes. B: Extent of coflotation of ∆TM2 RSPs with liposomes relative to the WT derived 
from three independent experiments. Error bars indicate the standard error of the mean. C: 
Fluorescence spectrum of liposome containing fractions from coflotation experiments with 
∆TM2 (grey) and WT (black line) RSPs. 
 
 
 
 
 
Excimer Peak 
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1.3.4. Role of TM2 for E trimer formation and stability 
 
 
 
Since ∆TM2 E dimers dissociated upon low pH treatment and stably interacted 
with target membranes via their fusion peptides like the wild-type, the block of 
fusion must be due to an interference with later stages of the fusion process, 
which includes the formation of E trimers. 
To examine the effect of the TM2 deletion on E trimerization, sedimentation 
analyses – in the presence of the detergent TX-100 – were carried out. WT- and 
∆TM2-RSPs were acidified, back-neutralized, solubilized with TX-100 and 
analyzed in continuous sucrose gradients as described before (Allison et al., 
1995, 2001) and in Materials and Methods.  
As shown in Figure 5, a quantitative conversion from dimers into trimers was 
observed for both, WT (Fig. 5 A) and ∆TM2 (Fig. 5 B), E proteins as revealed by 
a shift in sedimentation velocity.  
However, truncated E trimers lacking the whole stem-anchor region were 
previously shown to be less thermostable than full-length trimers. To test 
whether deletion of TM2 also affects trimer stability, thermal denaturation 
experiments were carried out (Stiasny, Koessl and Heinz, 2005; Fritz, Stiasny 
and Heinz, 2008). For this purpose, preparations of trimeric E (WT and ∆TM2) 
were incubated at 70°C for 10 min before sedimentation analysis. As shown in 
Figure 5 C, the oligomeric state of WT E was not affected, but ∆TM2 trimers 
were found to be sensitive to increased temperatures as revealed by a strong 
reduction of the trimer peak and the accumulation of presumably aggregated E in 
the pellet. 
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Figure 5. Low pH-induced trimer formation and thermostability of WT and ∆TM2 E. 
A and B: RSPs (A: WT; B: ∆TM2) were incubated at pH 5.4 (solid line) or 8.0 (dotted line), 
solubilized, and the oligomeric state of E was analyzed by sedimentation analysis. The 
sedimentation direction is from left to right. C: WT (black line, solid boxes) and ∆TM2 (grey line, 
open diamonds) E trimers were incubated at 70°C before sedimentation analyses. The E dimer is 
represented by the peak in fraction 8, the trimer by the peak in fraction 10. P indicates the pellet 
that was resuspended in the volume of a fraction (0.6 ml). 
 
 
 
 
 
 
Figure 6. Sequence of events in virus membrane fusion. (A) A hypothetic fusion protein in its 
pre-fusion conformation. (B) Initial interactions with a target membrane and formation of an 
extended intermediate structure. (C) Collapse of the extended intermediate. (D) Formation of a 
hemifusion stalk. (E): Opening of the fusion pore. From Harrison, 2008b. 
 
 
 
 
A Pre-fusion 
B Extended 
Intermediate 
C Collapse of 
Intermediate D Hemifusion E Fusion pore    (post-fusion) 
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1.4. Discussion 
 
 
 
The transmembrane domains of many viral fusion proteins have been shown to 
be required for efficient fusion, but their precise functional role – besides being a 
membrane anchorage domain – in this process is still unknown. Figure 6 depicts 
several stages of virus membrane fusion each of which could be influenced by 
the TMDs of viral fusion proteins.  
The initial contact of the fusion protein with the target membrane (Fig. 6 B) was 
found to be independent of the TMD of any fusion protein studied so far (Table 
1). In consistence with these findings, the experimental results presented in this 
study clearly show that there is no contribution of the second TMD of the TBEV E 
protein to the initial steps of flavivirus fusion. Early fusion events such as the 
dissociation of E dimers and stable interactions with target membranes were not 
affected by the lack of TM2.  
Later steps of virus fusion involve the formation of a trimeric cluster of the fusion 
proteins, the formation of the hemifusion state (Fig. 6 D) and the formation of the 
fusion pore (Fig. 6 E). Low pH-triggered TBEV E trimerization was found to be 
independent of the presence of TM2, but in contrast to the full length trimers, 
∆TM2 trimers were less thermostable. These results suggest a role of TM2 in 
late stages of flavivirus fusion. The overall fusion activity of ∆TM2 RSPs was 
assessed by in vitro lipid mixing assays and was found to be strongly impaired. 
Lipid mixing theoretically occurs during the hemifusion state. Therefore, the lack 
of TM2 in TBEV E apparently causes a block before the formation of the 
hemifusion stalk. Previously a strongly reduced hemifusion activity was only 
observed by the replacement of the HIV gp120 TMD (Miyauchi et al., 2005).  
There are several hypothetical mechanisms in E-mediated flavivirus membrane 
fusion that could involve TM2: (I) A hypothesis was established that suggests 
that viral fusion glycoproteins have to cluster and form multiprotein complexes to 
efficiently mediate fusion. For influenza fusion with red blood cells, it was shown 
that at least three HA trimers are required for a single fusion event (Danieli et al., 
1996), although this number may be dependent on the type of host cell 
(Harrison, 2008b). Cooperativity of fusion proteins may occur via lateral contacts 
between the fusion protein TMDs in a ring surrounding the fusion pore 
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(Chernomordik and Kozlov, 2003). Such ring complexes would be favored in 
overcoming the energy barrier for fusion. Clustering of fusion proteins via lateral 
interactions at the fusion site has been specifically proposed for the E1 protein of 
Semliki Forest virus (Gibbons et al., 2004) and for TBEV E (Stiasny et al., 2004). 
In the case of flaviviruses, the current results in this thesis allow the speculation 
that interactions between the second TMDs of adjacent E proteins – probably 
facilitating E trimer multimerization – occur during fusion. This hypothesis has to 
be tested experimentally in future research. It has to be taken into account, 
however, that theoretically the energy barrier to a hemifusion stalk (40-50 kcal 
mol-1) could be overcome by the refolding of just one or two trimers (Kuzmin et 
al., 2001; Yang et al., 2006; Harrison, 2008b). 
(II) It has been hypothesized that fusion proteins might disturb the integrity of 
membranes via their TMDs. The distortion of the membranes lowers the energy 
barrier for fusion (reviewed in Chernomordik and Kozlov 2008; Harrison, 2008b). 
TM2 of TBEV E could therefore be involved in lowering the energy barrier for the 
membranes to form the hemifusion intermediate, whereas in the case of 
influenza HA, the TM could be required for lowering the energy barrier for the 
transition from the hemifusion state to the opening of the fusion pore. 
(III) For full fusion to occur, a stable post-fusion trimer of E is necessary. The 
formation of this stable trimer could be dependent on TM1-TM2 interactions in 
the membrane. This theory, however, is in contrast to preliminary experimental 
results that show that the fusion activity of ∆TM2 RSPs can be rescued by the 
introduction of the corresponding – but not sequence homologous – TM2 of JEV 
(unpublished observation R. Fritz). These findings rather support a hypothesis in 
which a stable anchor requires the presence of an unspecific second TM 
element.  
A combination of the mechanisms discussed is also possible. In summary, the 
results presented here demonstrate an active role of the TMD of TBEV E in 
fusion. To further clarify this role, additional analyses are required. 
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V. PART III 
 
 
Preparatory work: 
Establishment of quality controls of recombinant 
subviral particles for flavivirus membrane fusion 
studies 
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1.1. Introduction 
 
 
 
Detailed investigations of viral membrane fusion – as presented in this thesis – 
require suitable experimental model systems. The use of replicating virions for 
experimental purposes is often time consuming and may be complicated by 
resuscitating mutations occurring during virus replication. This limitation is 
overcome by the use of recombinant non infectious subviral particles (RSPs), 
which – in the case of flaviviruses – contain the E and M proteins anchored in a 
lipid membrane (Fig. 1), but lack the nucleocapsid. Quality controls that help to 
identify RSPs suitable for membrane fusion studies were lacking and had to be 
established before such particles could be used in the previous parts of this 
thesis. 
RSPs can be produced by the co-expression of the E and prM proteins of TBE 
virus in eukaryotic cells (Allison et al, 1995a). Similar particles of different 
flaviviruses were obtained using various eukaryotic expression systems (Mason 
et al., 1991; Konishi et al., 1992; Pincus et al., 1992; Fonseca et al., 1994). Like 
the virions, RSPs are assembled at the membrane of the ER in an immature 
form containing a complex of E and prM. Immature RSPs (containing prM) 
encounter low pH conditions in the TGN that trigger a conformational change in 
the protein complex resulting in the maturation cleavage of prM by furin or a 
related protease.  
RSPs were extensively characterized and shown to be ordered structures 
containing envelope glycoproteins with structural and functional properties very 
similar to those in the virion envelope (Fig. 1). The structure of RSPs of TBEV 
was determined by cryo-electron microscopy (cryo-EM) and image 
reconstruction to a resolution of 19 Å (Ferlenghi et al, 2001). Fitting the high-
resolution structure of the E ectodomain into the experimental density revealed 
that 30 E dimers are arranged in a T=1 icosahedral lattice. The structural 
similarity of E on RSPs and virions has further been shown by conformation-
sensitive and virus-neutralizing monoclonal antibodies. Incubation at pH <6.5 
induced identical conformational changes and structural rearrangements, 
including an irreversible, quantitative conversion of dimers into trimers (Allison et 
 100
al., 1995b; Schalich et al., 1996). RSPs were also shown to be functionally 
active, inducing membrane fusion in a low pH-dependent manner (Schalich et 
al., 1996; Corver et al., 2000). Therefore TBE virus RSPs are an excellent model 
system for investigating the structural basis of viral envelope glycoprotein 
functions. 
In this thesis several point mutations were introduced into E of TBEV RSPs (Part 
I) and the protein was truncated at its C-terminus (Part II). It had to be 
considered, however, that any mutation or truncation introduced into this 
experimental system could potentially interfere (A) with the formation/assembly 
of the particles, (B) with their maturation (prM cleavage) and (C) with their 
secretion from the host cell.  
The presence of high amounts of uncleaved prM in mutant RSPs is very critical 
because the chaperone prM prevents conformational changes in E that are 
necessary for mediating fusion. Information on the particle’s prM content can 
help to avoid misleading interpretations of experimental data. The amount of 
uncleaved prM present in RSP samples was quantitatively determined in a 
western blot assay.  
The secretion of the recombinant particles was quantitatively analyzed by the 
detection of E in the supernatant of transfected cells using a four layer ELISA 
format.  
The surface organization of every E mutant was analyzed by epitope mappings 
using a set of monoclonal antibodies (mabs) that recognize binding sites 
distributed all over the three E domains (Stiasny et al., 1996, 2007).  
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Figure 1. Representations of the structural organization of flavivirus virions and RSPs. 
(A): Schematic diagram of a subviral particle in both, its mature (right) and immature (left) form. 
During virus maturation prM is cleaved by an intracellular protease. This cleavage is 
responsible for the rearrangement of E dimers on the surface of mature virus particles. (B): 
Arrangement of the 30 E dimers in RSPs. (C) Arrangement of the 90 E dimers at the surface of 
a mature flavivirus particle. Drawn with PyMol. Color code: prM – green; E domain I – red; E 
domain II – yellow; E domain III – blue. 
 
 
 
 
 
 
300Ǻ 
(A) 
(B) 
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1.2. Results 
 
 
 
1.2.1. Maturation state analysis of RSPs 
 
The maturation state of RSPs was investigated by a western blot procedure 
using polyclonal sera, raised against TBEV, that detect all structural proteins 
(Materials and Methods). The assay was used to compare the amount of prM in 
mature WT RSPs with the amounts in completely immature ∆88 RSPs – that 
carry a mutation in the furin cleavage site and are therefore not amenable to 
maturation cleavage – and mutant RSPs with an unknown maturation state. The 
western blot detection limit of prM in RSP mutants was used as the read out. It 
had to be similar to WT particles to consider the mutants to be mature and 
unaffected in prM processing. 
Preparations of TBE virus and WT RSPs were used to establish the optimal 
blotting conditions and to identify the dilution range in which structural proteins 
would be detectable. It has been reported that in all flavivirus preparations a 
certain amount of uncleaved prM is present (Guirakhoo et al., 1991; Davis et al., 
2006; Nelson et al., 2008). Indeed prM was detectable in all of the WT samples 
(Fig. 2 A), but the degree did not vary between different preparations. ∆88 RSPs 
contained a significantly higher amount of prM (about 7.5 times more than the 
WT) and no cleaved membrane protein (M) was detectable (Fig. 2 B). The 
detection limit of prM in samples of ∆88 RSPs was 3 * 10-3 µg corresponding to 
60 uncleaved prM molecules and a sample dilution of 1:160 with little or no 
deviation, whereas in all WT samples prM could be detected up to a sample 
dilution of 1:20, corresponding to an average of 8 molecules of prM per particle 
(Fig. 2). Table 1 lists the results of mutant RSPs maturation state analysis and 
shows that most of the mutants that secreted particles were properly processed. 
Interestingly several H248 mutants as well as two double mutants showed 
increased contents of prM. 
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1.2.2. Secretion of mutant RSPs 
 
To determine whether certain alterations of E impair the assembly or the 
secretion of TBEV RSPs, and to investigate the specific aims described in this 
thesis, such particles were produced by electroporation of Cos-1 cells with 
plasmids encoding TBEV prM and E (WT and mutants). Cell culture 
supernatants that were harvested and cleared 48 hours after transfection were 
subjected to ultracentrifugation and the amounts of protein E in the pellet 
fractions was quantified in a four layer ELISA.  
As shown in Table 1, substitutions that did not abolish particle formation and 
secretion were found for most of the target amino acids. However, not every 
substitution was tolerated as demonstrated by the mutations introduced at 
residue 323 of TBEV E (Table 1). Alanine and glutamine substitutions in this 
position led to the secretion of particles with the same efficiency as the wild-type, 
whereas in the case of exchanges to isoleucine, asparagine, lysine or aspartate 
no particles were found in the pelleted cell culture supernatants. Replacement of 
conserved histidine 146 by any of the other 19 amino acids prevented the 
formation and/or the secretion of RSPs (Table 1) (Fritz, Stiasny and Heinz, 
2008).  
To test the importance of interactions at the domain I-III interface, the residues 
building the prominent interdomain salt bridge, Arg9 and Glu373, as well as 
surrounding residues 42 and 358 were mutated. With none of these mutants 
particle secretion was observed (Table 1; Fig. 4).  
 
 
1.2.3. Epitope mapping of mutant E 
 
To verify the structural integrity of E on mutant RSPs, their reactivity with a set of 
22 mabs was tested in epitope mappings. WT particles showed a distinct 
reactivity pattern displayed in Figure 3 A.  
As depicted, some of the mabs – especially “A mabs” and 8H1 - showed an 
altered reactivity with ∆88- compared to WT-RSPs (Fig. 3 A). Most of the 
mutants followed the WT pattern as demonstrated in Figure 3 B and Table 1. 
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Certain mutations, however, shifted the reactivity profile to the ∆88 pattern as it 
was the case for mutant H248I (Fig. 3 C, Table 1). 
In correspondence with the western blot results, these findings revealed 
differences in the surface organization of mutant E in RSPs indicating that in 
some mutants uncleaved prM was present.  
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Figure 2. Maturation state analysis of RSPs by western blotting. Shown are dilution 
series of WT RSPs (A) compared to ∆88 RSPs (B). E indicates the bands of the envelope 
protein, prM indicates the bands of the uncleaved membrane protein precursor (M). Red bars 
indicate the prM detection limits. Results are examples from 8 independent experiments with 
similar results. 
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Figure 3. Representative examples of epitope mappings obtained with mutant RSPs. 
Shown is the reactivity pattern of selected monoclonal antibodies with WT RSPs (green line; 
A and B), ∆88 RSPs (red line; A and C), H323A RSPs (orange line; B) and H248I RSPs 
(salmon line; C). Error bars represent the standard deviation of the mean and are derived 
from 3-4 independent experiments. 
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Table 1 Summary of quality control analysis performed with WT and mutant TBEV RSPs 
 
Mutant 
 
Secretiona 
 
prM processingb 
 
Epitope mapping 
 
WT 
∆88 
 
+ 
+ 
 
+ 
- 
 
WT 
∆88 
R9A - ND ND 
R9E 
R9G 
R9I 
R9K 
R9P 
R9Q 
R9T 
R9Y 
D42A 
D42N 
H146A 
H146C 
H146D 
H146E 
H146F 
H146G 
H146I 
H146K 
H146L 
H146N 
H146P 
H146Q 
H146R 
H146S 
H146T 
H146V 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
 
+: WT-like secretion or processing; -: negative secretion or processing; 
a: mutants with negative secretion were not amenable to further invsttigation;  
b: mutants defective at the processing stage were not further investigated; ND: not determined 
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Table 1 continued 
 
Mutant 
 
Secretiona 
 
prM processingb 
 
Epitope mapping 
 
H146W 
H146Y 
 
- 
- 
 
ND 
ND 
 
WT 
ND 
H248A 
H248I 
H248K 
H248N 
H248Q 
H287A 
H287G 
H287K 
H287Q 
H323A 
H323D 
H323I 
H323K 
H323N 
H323Q 
I358S 
I358G 
E373A 
E373D 
E373H 
E373I 
E373K 
H438A 
H438I 
H438K 
H438N 
H438Q 
+ 
+ 
+ 
+ 
+ 
+ 
- 
- 
- 
+ 
- 
- 
- 
- 
+ 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
+ 
+ 
- 
- 
- 
+ 
- 
+ 
ND 
ND 
ND 
+ 
ND 
ND 
ND 
ND 
+ 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
+ 
ND 
ND 
∆88 
∆88 
WT 
ND 
WT 
ND 
ND 
ND 
WT 
ND 
ND 
ND 
ND 
WT 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
WT 
ND 
 
 
+: WT-like secretion or processing; -: negative secretion or processing; 
a: mutants with negative secretion were not amenable to further invsttigation;  
b: mutants defective at the processing stage were not further investigated; ND: not determined 
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Table 1 continued 
 
Mutant 
 
Secretiona 
 
prM processingb 
 
Epitope mapping 
 
∆TM2 
 
+ 
 
+ 
 
WT 
R9E-E373R 
H287A-H323A 
H287G-H323Q 
H248N-H287A 
H248N-H323A 
H248N-H438N 
H287A-H438N 
H323A-H438N 
H248N-H287A-438N 
 
- 
+ 
- 
+ 
+ 
+ 
+ 
+ 
+ 
ND 
- 
ND 
+ 
+ 
+ 
+ 
- 
+ 
ND 
ND 
ND 
WT 
WT 
WT 
WT 
ND 
WT 
 
 
+: WT-like secretion or processing; -: negative secretion or processing; 
a: mutants with negative secretion were not amenable to further invsttigation;  
b: mutants defective at the processing stage were not further investigated; ND: not determined 
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1.3. Discussion 
 
 
RSPs have been shown to be valuable tools for studying flavivirus membrane 
fusion. Here methods are described that allow the identification of mature RSP 
mutants that carry the E protein in a WT-like conformation. 
A western blot based assay was developed to compare the amounts of prM 
found in WT and mutant particles. It is an interesting finding of this work that 
most histidine 248 mutants were shown to contain amounts of prM comparable 
to immature ∆88 particles (Table 1). Two recently published reports on the 
structure of the prM-E complex of dengue 2 virus suggested the involvement of a 
homologous histidine in interactions between prM and E required for maturation 
(Li et al., 2008; Yu et al., 2008). A H248N mutant, however, was identified as 
perfectly mature in this study. Therefore, it remains a matter of speculation which 
residues are involved in the pH dependent processes of prM cleavage and pr 
peptide dissociation. The results obtained from the maturation state analyses 
were consistent with the epitope mappings, e.g. mutant H248I showed a 
mapping pattern very similar to ∆88 RSPs (Fig. 3 C) and was shown to contain 
the same amount of prM (Table 1). 
The fact that also WT RSPs contained some uncleaved prM indicates that 
complete maturation is not a prerequisite for efficient membrane fusion. It is an 
interesting question whether the surface of native RSPs and virus particles is 
covered by heterogeneous E/E and prM/E complexes in varying ratios (mixed 
particles) or whether there are mature and immature single particles within a 
mixed population. 
The results of the investigation of mutant RSP secretion demonstrate that the 
introduction of mutations in the RSP system can lead to the abolishment of 
particle formation and/or secretion. Specifically some residues located at the 
highly conserved stretch between domains I and III were found to be essential 
for the formation/secretion of particles. The structural integrity of this domain 
interface depends on an interdomain salt bridge built by residues 9 and 373 
respectively. Histidine 146 is located in close vicinity at the same interface (Fig. 
4). None of these residues could be exchanged without loss of particle secretion 
and/or formation (Table 1).  
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The methods established were essential for selecting those RSPs that could be 
used in the previous parts for dissecting the fusion process. They can also be 
useful in future research on flavivirus assembly and maturation. 
 
 
 
 
 
 
 
Figure 4. Residues in TBEV E that could not been mutated without loss of RSP 
formation or secretion. Ribbon diagram of the domains I/III interface of E. Residues that 
were identified to be critical for the assembly/secretion of RSPs are highlighted as grey 
sticks. Conserved ones are underlined. Drawn with PyMol. 
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VI. OUTLOOK 
 
 
 
It is estimated that the number of worldwide flavivirus infections per year with 
severe illness symptoms exceeds 50 million. Icterus, haemorrhagic fever and 
encephalitis are only a few possible disease manifestations in humans caused 
by infections with different flaviviruses. Therefore, yellow fever virus (YFV), 
dengue virus (DenV), Japanese encephalitis virus (JEV), West nile virus (WNV), 
and tick-borne encephalitis virus (TBEV), are among the most important human 
pathogenic viruses worldwide. Still, effective vaccination is only available for 
three of the mentioned viruses, i.e. YFV, JEV and TBEV (reviewed in Pugachev, 
Guirakhoo and Monath, 2005; Gould and Solomon, 2008). New, innovative 
vaccines are in development; but additional preventive and therapeutic 
approaches are desirable, including the development of antiviral agents.  
Among the greatest breakthroughs in studying viral membrane fusion were the 
structure determinations of viral fusion proteins starting with the influenza HA 
(Wilson, Skehel and Wiley, 1981). Since then, several structures of fusion 
proteins were resolved allowing their subdivision into distinct structural classes 
and the development of viral membrane fusion models. Enhanced knowledge of 
the structural basis of flavivirus cell entry can lead to the design of specific small 
molecules that block virus entry by selectively binding to the fusion proteins. 
The only fusion inhibitor currently available, however, is for treatment-
experienced HIV patients. Enfuvirtide (Fuzeon by Roche, Trimeris) was the first 
licensed peptide drug targeting a highly conserved pocket of the HIV-1 fusion 
protein, thus inhibiting extracellular fusion of HIV-1 to host cells (reviewed in 
Matthews et al., 2004). Enfuvirtide is a 36 amino acids L-peptide drug with the 
ability to prevent gp41 – the subunit of the HIV fusion protein functionally related 
to influenza HA2 (Weissenhorn et al., 1997) and derived from cleavage of the 
gp160 precursor protein – from undergoing conformational changes that enables 
it to fuse the viral and cellular membranes. But the peptide is sensitive to 
protease degradation, expensive to produce and it has to be injected 
subcutaneously twice daily. These limitations were overcome by the 
development of D-peptide entry inhibitors – where D- instead of L-amino acids 
 113
are present – that are resistant to proteases and can be administered orally 
(Eckert et al., 2001). Such D-peptides with antiviral potency are currently under 
preclinical investigation (Welch, et al., 2007, 2008).  
In contrast to HIV, there are currently no fusion inhibitors for class II fusion 
proteins. The reasons, beside greater scientific and pharmaceutical interest in 
the HIV epidemic, are that HIV fuses at the cell membrane, while flavi- and 
alphavirus fusion occurs intracellularly in endosomes. A class II fusion inhibitor 
therefore has to get into the endosomes, either with the virus or on its own. An 
additional problem could be that class II fusion proteins display the fastest fusion 
kinetics known, making it more difficult for small molecules to interfere with this 
process. Nevertheless a report describes the inhibition of membrane fusion 
mediated by SFV E1 and dengue E by the addition of exogenous domain III.  
DIII was shown to stably bind to the fusion protein, thus preventing the structural 
alterations of the fusion proteins and blocking lipid mixing (Liao and Kielian, 
2005). Soluble DIII of TBEV E lacking the whole stem did not block fusion of 
TBEV RSPs (unpublished observation R. Fritz). It remains to be elucidated 
whether a recombinant DIII plus parts of the stem can bind to the fusion protein 
efficiently. 
Capture and study of fusion intermediates may become an important issue in the 
flavivirus field. The structures of E already led to the identification of potential 
binding sites that are at least transiently accessible for small molecules 
inhibitors: A ligand-binding pocket that closes when the protein undergoes low 
pH-induced conformational changes (Modis et al., 2003) and further sites 
involved in inter- and intra-domain contacts during trimer formation (Bressanelli 
et al., 2004). Therefore, the most promising approach for the development of 
class II fusion inhibitors may be the structure-based design of molecules that 
target the flexibility of the E protein, specifically of the junction between DI and 
DIII.  
Beside the development of fusion inhibitors, future research on flavivirus fusion 
will focus on exploring potential cooperativity of fusion protein trimers for 
mediating full fusion and the involvement of the transmembrane domains in this 
process. The role of conserved histidines in the fusion protein for other purposes 
than initiating fusion – for example virus maturation – will be another subject of 
future research that is poorly understood to date.  
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VII. MATERIALS AND METHODS 
 
 
 
1. 1. Plasmid Construction 
 
All mutations were introduced into the recombinant SV-PE wt plasmid (Allison et 
al. 1994) - containing the TBEV prM and E genes under the control of an SV40 
early promoter - by the use of the site directed mutagenesis kit Gene Tailor 
(Invitrogen). The ∆TM2 deletion mutant was constructed by the substitution of a 
SnaBI-NotI fragment, within the SV-PE wt plasmid, with a PCR generated 
sequence carrying a TAG codon at position 473 of E followed by a NotI 
restriction site (Allison et al., 1999). Both strands of the plasmids were 
sequenced to confirm the presence of the desired substitutions or deletion and 
the absence of any undesired mutations. 
 
 
1.2. Recombinant subviral particle production 
 
RSPs were produced by electroporation of COS-1 cells with WT and 
recombinant plasmids as described previously (Allison et al., 1995; Schalich et 
al., 1996). 48 hours posttransfection particles secreted into the cell culture 
supernatant were harvested by ultracentrifugation for 2h at 44,000 rpm and 4°C. 
Pelleted RSPs were resuspended in TAN pH 8.0 buffer (50 mM triethanolamine, 
100 mM NaCl). For coflotation and lipid mixing experiments the particles were 
purified in continuous sucrose gradients. For lipid mixing assays, the particles 
were labelled with 1-pyrenehexadecanoic acid (Molecular Probes) as described 
previously (Corver et al., 2000).  
 
 
1.3. Quantification of secreted particles by ELISA 
 
The amount of RSPs secreted from transfected Cos cells was quantitatively 
determined in a 4-layer ELISA (Heinz et al., 1994). Microtiter plates were coated 
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at 4°C with guinea pig anti-TBE virus IgG in carbonate coating buffer pH 9.6. 
Purified TBE virus – with a known protein concentration – serving as standard 
and the samples were denatured with 0.4% sodium dodecyl sulfate (SDS) for 30 
minutes at 65°C. Standard and samples were serially diluted in PBS pH 7.4, 
containing 2% lamb serum and 2% Tween 20, transferred to the coated plates, 
and incubated for 1.5 hours at 37°C. After washing with PBS pH 7.4 (0.05% 
Tween 20), a polyclonal rabbit anti TBE serum was added and allowed to bind 
for 1 hour at 37°C. Bound antibodies were detected by 1 hour incubation with 
horseradish peroxidase labelled donkey anti-rabbit IgG and 
orthophenyldiamine/H2O2 as substrate. After 30 minutes the reaction was 
stopped by adding 100 µl 2N H2SO4 to each well. The absorbance was 
determined with an ELISA reader at 490 nm. 
 
 
1.4. Epitope mapping 
 
Epitope mappings of WT and mutated E in RSPs were performed in a four layer 
ELISA format using a panel of E protein specific mabs (Allison et al., 1995a, 
2001; Stiasny et al., 2005). Microtiter plates were coated at 4°C with guinea pig 
anti-TBE virus IgG in carbonat coating buffer pH 9.6. WT and mutant RSPs were 
added at a concentration of 0.5 µg E  / ml in a total volume of 50 µl PBS pH 7.4, 
containing 2% lamb serum and 2% Tween 20, and were allowed to bind for 1 
hour at 37°C. Various E specific mabs were added in a predefined dilution to 
yield an absorbance of about 1.0 at 490 nm. After one hour incubation at 4°C, 
mabs bound to E were detected with horseradish peroxidase labelled rabbit anti-
mouse IgG and orthophenyldiamine/H2O2. The reaction was stopped with 100 µl 
2N H2SO4 per well and the absorbance was measured in an ELISA reader.  
 
 
1.5. Maturation state analysis  
 
The particle’s maturation state was determined by the quantification of the 
relative amount of prM by western blotting. RSPs at a concentration of 0.5 µg E 
protein / 50 µl Laemmli sample buffer were boiled at 100°C for 5 min. Samples 
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were diluted 6 times 1:1 in Laemmli buffer, boiled again and 20 µl of each 
dilution were applied to 15% acrylamide gels. Immature virus was used as a 
positive prM control. SDS gel electrophoresis was carried out using Mini Protean 
II gel apparatuses (BioRad). After electrophoresis, gels were equilibrated for 10 
min in blotting buffer (48mM Tris, 39mM Glycine, 1.3mM SDS, 20% methanol) to 
avoid shrinking during blotting. PVDF membranes (BioRad) were incubated in 
methanol for 5 min and then soaked in blotting buffer together with the filter 
papers used for blotting (BioRad) for 15 min. Western blotting was performed 
with the semidry blotter Trans-Blot SD from BioRad (18 V, 90 min). PVDF 
membranes were then saturated by overnight incubation in blocking buffer (PBS 
pH 7.4, 1% BSA, 0.1% Tween 20) at 4°C under constant shaking. Blot 
development was done by incubation with an anti TBEV polyclonal rabbit serum 
– that recognizes all structural proteins (E, prM, M, C) – in blocking buffer and 
bound antibodies were detetced with horseradish peroxidase labelled donkey 
anti-rabbit IgG and Sigma FastTM tablets by Sigma Aldrich. 
 
 
1.6. Liposomes 
 
Liposomes were prepared as described previously (Stiasny, Koessl and Heinz, 
2003; Stiasny et al., 2007). Phosphatidylcholine, phosphatidylethanolamine 
(Avanti Polar Lipids) and cholesterol (Sigma) were mixed at a molar ratio of 1:1:2 
in chloroform. The mixture was dried to a homogenous film in high vacuum and 
hydrated in liposome buffer (10 mM triethanolamine, 140 mM NaCl) by 5 freeze 
thaw cycles. Prior to use liposomes were subjected to 21 extrusion cycles 
through polycarbonate membranes with 200 nm pores (Avestin) using a 
LiposoFast-Basic extruder (Avestin). 
 
 
1.7. Lipid mixing assay    
 
Lipid mixing was measured by monitoring the decrease in pyrene excimer 
fluorescence caused by the dilution of pyrene-labelled phospholipids in the RSP 
membrane into an unlabeled liposomal membrane (Corver et al., 2000). Pyrene-
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labelled RSPs were mixed with liposomes (total lipid 0.3 mM) in a continuously 
stirred fluorimeter cuvette at 37°C in liposome buffer. Lipid mixing was induced 
by the addition of 50µl 300 mM morpholinoethansulfonic acid (MES) to yield a 
pH of 5.4. To controls the same volume of TAN pH 8.0 buffer was added. 
Fluorescence was continuously recorded for 120s by a Perkin-Elmer LS-50B 
fluorescence spectrophotometer at 480 nm. The initial pyrene excimer 
fluorescence before acidification was defined as 0% fusion extent and the 
fluorescence after solubilization of the RSP-liposome mixture by the detergent 
octa(ethylene glycol)-n-dodecyl monoether (Fluka) as 100% fusion. Based on 
these data the extent of fusion of each sample was calculated 
 
 
1.8. Fusion peptide exposure  
 
Microtiter plates were coated with polyclonal anti-TBE virus IgG in carbonate 
coating buffer pH 9.6 to capture WT and mutant RSPs at a concentration of 0.5 
µg E / ml in PBS pH 7.4, containing 2% lamb serum as described previously 
(Stiasny et al., 2007). After 1 hour incubation at 37°C the FP specific biotinylated 
mab A1 was added at a concentration of 0.25 µg/ml in MES buffer (50 mM MES, 
100 mM NaCl), titrated to pHs between 7.0 and 5.4 using 1N NaOH (Fritz, 
Stiasny and Heinz, 2008). The bound antibody A1 was detected by using a 
streptavidin peroxidase (Sigma-Aldrich) and orthophenyldiamine/H2O2. The 
reaction was stopped with 100 µl 2N H2SO4 per well and the absorbance was 
measured in an ELISA reader at 490 nm. 
 
 
1.9. Coflotation of RSPs with liposomes 
 
RSPs were mixed with liposomes at a ratio of 1 µg E to 200 nMol lipids and 
incubated at 37°C for 10 min. The RSP-liposome mixture was then acidified with 
300 mM MES and incubated at 37°C for 15 min. TAN buffer pH 8.0 was added 
instead of MES to controls. Acidified samples were back-neutralized to pH 8.0 by 
the addition of 150 mM triethanolamine. Then the samples were adjusted to 20% 
sucrose (w/w) in a final volume of 0.6 ml. Samples were applied to a 1 ml 50% 
sucrose cushion and overlaid with 1.4 ml 15% sucrose and 1 ml 5% sucrose as 
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described before (Allison et al., 2001; Fritz, Stiasny and Heinz, 2008). 
Centrifugation was carried out at 50,000 rpm and 4°C for 2 hours in a Beckmann 
SW 55 rotor. 0.2 ml fractions were collected by upward displacement using a 
Piston Gradient Fractionator (BioComp Instruments Inc.) and the amount of E 
protein in each fraction was quantified by four-layer ELISA (Heinz et al., 1994). 
 
 
1.10. Sedimentation analysis 
 
The oligomeric state of E – after incubation of RSPs at acidic or neutral pH – 
was determined by sedimentation analysis as described previously (Allison et 
al., 1995, 2001). 3 µg subviral particles in TAN buffer pH 8.0 were incubated for 
10 min at pH 5.4 or 8.0 by the addition of 300 mMES or TAN pH 8.0, 
respectively. Acidified samples were back-neutralized with 150 mM 
triethanolamine and all samples were solubilised with 1% Triton-X 100 for 1 hour 
at room temperature. The samples were then applied on top of 7-20% 
continuous sucrose gradients (w/w) containing 0.1% Triton-X 100. Centrifugation 
was carried out at 38,000 rpm and 15°C for 20 hours in a Beckmann SW 40 
rotor. Fractions of 0.6 ml were collected by upward displacement using a Piston 
Gradient Fractionator (BioComp Instruments Inc.). The amount of E in the 
fractions was determined by a quantitative four-layer ELISA as above. 
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ABBREVIATIONS 
 
 
AcMNPV  Autographa californica multicapsid nucleopolyhedrovirus  
BSA  bovine serum albumin 
C   capsid 
D   domain 
DenV  dengue virus 
E   envelope 
ELISA  enzyme linked immunosorbent assay 
FP   fusion peptide 
HIV  human immunodeficiency virus 
HSV  herpes simplex virus 
JEV  japanese encephalitis virus 
M   membrane 
mab  monoclonal antibody 
MES  2-morpholinoethansulfonic acid  
NS  non structural 
ORF  open reading frame 
PBS  phosphate buffered saline 
PC  phosphatidylcholine 
PE   phosphatidylethanolamine 
RSP  recombinant subviral particle 
SFV  Semliki Forest virus 
sE   soluble envelope protein 
TBEV  tick-borne encephalitis virus 
TGN  trans-Golgi network 
TM  trans-membrane 
TMD  trans-membrane domain 
VSV  Vesicular stomatitis virus 
WNV  West Nile virus 
WT  wild-type 
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APPENDIX 
 
 
 
Kurzfassung 
 
Flaviviren sind kleine membran-umhüllte RNA Viren, die in vielen Fällen durch 
Stechmücken oder Zecken auf ihre Vertebratenwirte übertragen werden. Die 
wichtigsten humanpathogenen Vertreter sind das Frühsommer-Meningo-
Enzephalitis (FSME) Virus, das Gelbfieber Virus, das West Nil Virus, das 
Japanische Encephalitis Virus und die Dengue Viren. Die Infektion einer 
Wirtszelle durch umhüllte Viren erfordert die Verschmelzung (Fusion) der viralen 
mit einer zellulären Membran um die genetische Information der Viren in das 
Zellzytoplasma freizusetzen. Im Fall der Flaviviren erfolgt diese Membranfusion 
mit einer endosomalen Membran – nach Aufnahme durch Rezeptor-vermittelte 
Endozytose – und wird durch den sauren pH-Wert im Endosom ausgelöst. 
Dieser Prozess wird durch das virale Oberflächenglykoprotein E – ein Klasse II 
Fusionsprotein – gesteuert, das auf der Oberfläche infektiöser Viren als 
metastabiles, dimeres Molekül vorliegt. Saurer pH löst in diesem Protein 
dramatische Änderungen der Konformation und Oligomerstruktur aus, die die 
beiden Membranen in Kontakt bringen und schließlich zu ihrer Fusionierung 
führen. Es wurde die Hypothese aufgestellt, dass hochkonservierte Histidine in E 
als molekulare pH Sensoren fungieren und durch ihre Protonierung die Fusions-
relevanten Konformationsänderungen auslösen.  
Im Hauptteil dieser Dissertation wurden die fünf bei allen Flaviviren 
konservierten Histidine des E Proteins in rekombinanten Virus-ähnlichen Partikel 
(RSPs) des FSME Virus mutiert und die Auswirkungen der Substitutionen auf 
die verschiedenen Schritte des Fusionsprozesses analysiert. Dabei stellte sich 
heraus, dass einem Histidin (H323) an der Grenzfläche zwischen zwei Domänen 
von E eine zentrale und essentielle Rolle als pH Sensor zur Fusionsauslösung 
zukommt, während Histidine ausserhalb dieser Region keine Rolle bei der 
Initiierung der Membranfusion spielen. 
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Weitere Experimente waren der Aufklärung der Rolle des Membranankers des E 
Proteins im Fusionsmechanismus gewidmet. Im Gegensatz zu allen anderen 
bekannte viralen Fusionsproteinen, ist das Flavivirus E Protein nicht nur über 
eine, sondern über zwei transmembranale Helices (TM1 und TM2) in der 
Virusmembran verankert. Die Deletion von TM2 hatte zwar keinen Einfluss auf 
die Initiation und die frühen Phasen der Fusion, aber der Prozess wurde in 
einem intermediären Stadium blockiert und es kam nicht zur Bildung einer 
Fusionspore. Die experimentellen Befunde weisen darauf hin, dass dieser Effekt 
auf einen Stabilitätsverlust des in späten Stadien der Fusion gebildeten E 
Trimeren zurückzuführen ist. 
Die genaue Kenntnis der einzelnen Schritte des Fusionsmechanismus kann 
einen wichtigen Beitrag zur Entwicklung antiviraler Agenzien leisten, wie das 
Beispiel des AIDS Erregers HIV zeigt, gegen den bereits ein fusionshemmendes 
Medikament zur Verfügung steht. 
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Abstract 
 
Flaviviruses are small, enveloped RNA viruses. Most of them are transmitted to 
their vertebrate hosts by mosquitoes or ticks. The most important human 
pathogenic flaviviruses are tick-borne encephalitis (TBE), yellow fever, West 
Nile, Japanese encephalitis, and dengue viruses. Infection of a host cell by any 
enveloped virus requires the fusion of the viral membrane with a cellular 
membrane to release the viral genome into the host cell’s cytoplasm. Flavivirus 
fusion occurs at endosomal membranes – following uptake via receptor-
mediated endocytosis – and is triggered by the acidic pH in the endosomes. This 
fusion process is mediated by the major envelope glycoprotein E – a class II viral 
fusion protein – that exists in a metastable, dimeric conformation at the surface 
of infectious virions. Acidic pH triggers dramatic rearrangements of the 
conformation and oligomeric structure of E that bring the two membranes in 
close proximity and finally result in their fusion. It has been hypothesized that 
conserved histidines in E function as molecular pH sensors and, by their 
protonation, initiate the fusion-relevant conformational changes. 
In this thesis, the five histidines of E that are conserved among all flaviviruses 
were mutated in recombinant subviral particles (RSPs) of TBE virus and the 
effects of these substitutions on the various stages of the fusion process were 
analyzed. The results showed that one histidine (H323), located at the interface 
of two domains of E, has a critical and essential role as pH sensor for triggering 
fusion, whereas conserved histidines located outside this interface were found to 
be completely dispensable for the initiation of membrane fusion.  
Further experimental work aimed at dissecting the functional role of the 
membrane-anchor of E in the fusion process. The flavivirus E protein is 
anchored in the viral membrane via two transmembrane helices (TM1 and TM2). 
This is in contrast to all other known viral fusion proteins that have only single 
transmembrane domains. The deletion of TM2 of E in TBE virus RSPs had no 
effect on initiation or the early steps of fusion, but the process was blocked at an 
intermediate stage, preventing the formation of a fusion pore. The experimental 
data indicates that this effect is due to a loss of stability of the E trimers formed 
at late stages of fusion. 
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The understanding of the details of the fusion process can contribute to the 
development of antiviral strategies, with one fusion inhibitor directed against HIV 
now a licensed drug. 
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